Skip to main content
eLife logoLink to eLife
. 2020 May 18;9:e55342. doi: 10.7554/eLife.55342

MeCP2 in cholinergic interneurons of nucleus accumbens regulates fear learning

Ying Zhang 1,†,, Yi Zhu 1,, Shu-Xia Cao 2,, Peng Sun 1, Jian-Ming Yang 1, Yan-Fang Xia 1, Shi-Ze Xie 1, Xiao-Dan Yu 1, Jia-Yu Fu 1, Chen-Jie Shen 1, Hai-Yang He 1, Hao-Qi Pan 1, Xiao-Juan Chen 1, Hao Wang 1, Xiao-Ming Li 1,3,
Editors: Mary Kay Lobo4, Kate M Wassum5
PMCID: PMC7259956  PMID: 32420873

Abstract

Methyl-CpG-binding protein 2 (MeCP2) encoded by the MECP2 gene is a transcriptional regulator whose mutations cause Rett syndrome (RTT). Mecp2-deficient mice show fear regulation impairment; however, the cellular and molecular mechanisms underlying this abnormal behavior are largely uncharacterized. Here, we showed that Mecp2 gene deficiency in cholinergic interneurons of the nucleus accumbens (NAc) dramatically impaired fear learning. We further found that spontaneous activity of cholinergic interneurons in Mecp2-deficient mice decreased, mediated by enhanced inhibitory transmission via α2-containing GABAA receptors. With MeCP2 restoration, opto- and chemo-genetic activation, and RNA interference in ChAT-expressing interneurons of the NAc, impaired fear retrieval was rescued. Taken together, these results reveal a previously unknown role of MeCP2 in NAc cholinergic interneurons in fear regulation, suggesting that modulation of neurons in the NAc may ameliorate fear-related disorders.

Research organism: Mouse

Introduction

MeCP2 is a nuclear protein involved in the transcriptional repression of target genes (Chahrour and Zoghbi, 2007; Lyst and Bird, 2015; Qiu, 2018). Mice lacking Mecp2 can reproduce various Rett syndrome (RTT) phenotypes, including motor dysfunction, anxiety behavior, abnormal social behavior as well as impaired learning and memory (Shahbazian et al., 2002; Gemelli et al., 2006; Adachi et al., 2009; Ito-Ishida et al., 2015; Chao et al., 2010; Fyffe et al., 2008; Chen et al., 2001; Guy et al., 2001; Moretti et al., 2006). However, the mechanisms underlying learning and memory deficits remain poorly characterized. Given the important role of cholinergic neurons in learning and memory (Jiang et al., 2016; Brown et al., 2012; Picciotto et al., 2012; Letzkus et al., 2011; Likhtik and Johansen, 2019; Hasselmo, 2006; Yu and Dayan, 2005; Aitta-Aho et al., 2018), we proposed that conditional deletion of Mecp2 from cholinergic neurons may result in fear encoding dysfunction.

There are two primary sources of acetylcholine in the brain, that is, projection neurons located in the pedunculopontine, medial habenula, and basal forebrain (BF), and local interneurons located in the striatum and NAc (Aitta-Aho et al., 2018; Floresco, 2015; Kreitzer, 2009; Ren et al., 2011). Our previous study suggested that cholinergic projection neurons of the BF may contribute to impaired social interaction, decreased anxiety- and depression-like behaviors as well as elevated epilepsy susceptibility in Mecp2-deficient mice, with no effect on hippocampus-dependent learning and memory (Zhang et al., 2016b). Although MeCP2 is highly expressed in NAc neurons (Deng et al., 2010), relatively little is known about how MeCP2 regulates NAc cholinergic interneuron function. Despite the paucity of cholinergic interneurons in the NAc, acetylcholine signaling is directly required for the modulation of local circuit activity and associative learning (Cardinal et al., 2002; Luchicchi et al., 2014; Mamaligas and Ford, 2016; Picciotto et al., 2012; Shen et al., 2005; Witten et al., 2010; Brown et al., 2012; Hikida et al., 2016; Lee et al., 2016). Additionally, clinical research has implicated the NAc as one of the affected brain regions in RTT patients (Reiss et al., 1993; Subramaniam et al., 1997). Considering these findings, investigating the potential role of MeCP2 in regulating the function of NAc cholinergic interneurons in associative learning and memory would be of interest.

In this study, we achieved MeCP2 deletion primarily in cholinergic neurons by crossing ChatCre mice with mice carrying the loxp-flanked allele (Mecp2flox/-). We found that MeCP2 in NAc cholinergic interneurons participate in fear regulation. We also revealed that NAc cholinergic interneurons bi-directionally regulate fear learning. We further observed a robust reduction in NAc cholinergic interneuron activity in Mecp2-deficient mice, which could be attributed to elevated α2-containing GABAA receptors. With MeCP2 restoration, opto- and chemo-genetic activation, and RNA interference in NAc cholinergic interneurons, the impaired fear retrieval could be rescued. Taken together, we explored the cellular and molecular mechanisms underlying learning and memory deficits in a mouse model of RTT and discovered a previously unknown role of the NAc in regulating fear learning.

Results

Chat-Mecp2-/ymice exhibited deficits in fear learning

We first deleted Mecp2 specifically from cholinergic neurons by crossing ChatCre mice with mice carrying the loxp-flanked allele (Mecp2flox/-), hereafter referred to as Chat-Mecp2-/y mice. Fluorescent immunohistochemistry results demonstrated a remarkable reduction in the expression of MeCP2 in the cholinergic neurons of Chat-Mecp2-/y mice (Figure 1A–E), thus confirming the efficiency of Mecp2 deletion. We then examined Chat-Mecp2-/y mice under fear conditioning. A train of tone (30 s, 87 db) was used as conditioned stimulus (CS) and the electric footshock (0.5 mA, 1.5 ms) was used as unconditioned stimulus (US). CS was paired with US in a neural context for four trials in the training procedure. After pairing, mice were exposed to CS presented alone (context or tone) on the second day. The Chat-Mecp2-/y mice displayed increased freezing across trials in the training day (Figure 1F). However, compared to the other three control groups, freezing time of Chat-Mecp2-/y mice was significantly decreased on the last trial, suggesting an impairment in fear learning (Figure 1—figure supplement 1A). In the context and tone retrieval test, Chat-Mecp2-/y mice also showed decreased freezing time (Figure 1G,H). The difference in retrieval test with Chat-Mecp2-/y mice disappeared after normalizing to the last trial in the training day, further supporting the fear learning deficits (Figure 1—figure supplement 1B,C). The Chat-Mecp2-/y mice exhibited normal ability in pain detection (Figure 1—figure supplement 1D). We also explored whether Chat-Mecp2-/y mice showed spontaneous immobility behavior. The Chat-Mecp2-/y mice demonstrated normal locomotor activity without significant differences in immobility time in the open field tests (Figure 1—figure supplement 1E,F). Furthermore, these mice showed no deficit in the Y maze (Figure 1—figure supplement 1G) or Morris water maze tests (Zhang et al., 2016b), suggesting normal working and spatial memory ability.

Figure 1. Depletion of MeCP2 in Cholinergic Neurons Resulted in Impaired Fear Regulation.

(A, B) Fluorescence images showing NAc (A) and MS sections (B) in ChatCre mice stained for ChAT, MeCP2, and DAPI. (C, D) Fluorescence images showing NAc (C) and MS sections (D) in Chat-Mecp2-/y mice stained for ChAT, MeCP2, and DAPI. (E) Percentage of MeCP2 expression in NAc or MS of ChatCre or Chat-Mecp2-/y mice. P-values were calculated by two-tailed unpaired t-test. t = 95.73, df = 11, p<0.0001 for NAc. t = 281.8, df = 5, p<0.0001 for MS. n = 6 sections from four mice (NAc in ChatCre mice), 4 sections from four mice (MS in ChatCre mice), 7 sections from three mice (NAc in Chat-Mecp2-/y mice), 3 sections from three mice (MS in Chat-Mecp2-/y mice). (F) No significant change was detected in fear learning. P-values were calculated by two-way analysis of variance (ANOVA) with Tukey’s multiple comparisons test. F (9, 153)=1.895, p=0.0565. (G, H) Chat-Mecp2-/y mice showed decreased percentage of time freezing in context retrieval (G) and tone retrieval (H). P-values were calculated by one-way ANOVA with Bonferroni’s multiple comparisons test. F (3, 51)=4.445, p=0.0075 for (G). F (3, 51)=3.941, p=0.0132 for (H). n = 13 (WT), 15 (ChatCre), 15 (Mecp2flox/y), 12 (Chat-Mecp2-/y) mice. NAc: nucleus accumbens. MS: medial septum. WT: wild type mice. ChAT: Choline acetyltransferase, as a marker for cholinergic neurons. Data are means ± SEM. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, ####p<0.0001. NS means no significance.

Figure 1—source data 1. Statistical reporting of Figure 1.

Figure 1.

Figure 1—figure supplement 1. Chat-Mecp2-/y Mice Showed Normal Ability in Pain Perception, Movement Ability, and Working Memory, Related to Figure 1.

Figure 1—figure supplement 1.

(A) Chat-Mecp2-/y mice showed decreased freezing time compared to combination of other three control groups on Trial four during fear learning. P-values were calculated by two-tailed unpaired t-test. t = 2.228, df = 53, p=0.0302. n = 43 for control group, n = 12 neurons for Chat-Mecp2-/y group. (B, C) Freezing was measured against trial four during learning. P-values were calculated by one-way analysis of variance (ANOVA) with Bonferroni’s multiple comparison test. F (3, 51)=1.007, p=0.3975 for context fear. F (3, 51)=7.729, p=0.0002 for tone fear. n = 13 (WT), 15 (ChatCre), 15 (Mecp2flox/y), 12 (Chat-Mecp2-/y) mice. (D) Chat-Mecp2-/y mice showed normal response to increasing footshock intensity. P-values were calculated by one-way analysis of variance (ANOVA) with Bonferroni’s multiple comparisons test. F (2, 36)=0.8018, p=0.4563 for flinch. F (2, 35)=1.837, p=0.1743 for jump. F (2, 29)=1.044, p=0.3650 for vocal. n = 15 (ChatCre), 11 (Mecp2flox/y), 13 (Chat-Mecp2-/y) in flinch. n = 15 (ChatCre), 10 (Mecp2flox/y), 13 (Chat-Mecp2-/y) in jump. n = 12 (ChatCre), 9 (Mecp2flox/y), 11 (Chat-Mecp2-/y) in vocal. (E) Chat-Mecp2-/y mice showed normal movement ability in open field arena (15 min). P-values were calculated by two-tailed unpaired t-test. t = 0.3300, df = 8, p=0.7499. n = 5 (ChatCre), 5(Chat-Mecp2-/y). (F) Chat-Mecp2-/y mice showed normal immobility time in open field test. P-values were calculated by two-tailed unpaired t-test. t = 1.007, df = 8, p=0.3436. n = 5 (ChatCre), 5 (Chat-Mecp2-/y). (G) Chat-Mecp2-/y mice showed normal working memory in Y maze test. P-values were calculated by two-tailed unpaired t-test. t = 0.8772, df = 8, p=0.4059. n = 5 (ChatCre), 5(Chat-Mecp2-/y). Data are means ± SEM. *p<0.05, NS means no significance.

These results indicate that conditional deletion of Mecp2 from cholinergic neurons results in impaired fear learning.

Restoration of Mecp2 in NAc cholinergic interneurons rescued fear learning in Chat-Mecp2-/ymice

To unravel which population of cholinergic neurons contributes to the behavioral features observed in Chat-Mecp2-/y mice, we injected the AAV-FLEX-Mecp2-GFP (AAV/Mecp2) vector into different brain areas to specifically restore Mecp2 in cholinergic neurons, as described previously (Zhang et al., 2016b). We employed immunohistochemistry to confirm the recombination efficiency of the AAV/Mecp2 virus (Figure 2A) and revealed that ~73% of ChAT positive neurons were infected by the AAV virus and over 85% of GFP-labeled neurons were stained positively for MeCP2 in the NAc (Figure 2B; Figure 2—figure supplement 1A,B). To test the behavioral effects of MeCP2 restoration in cholinergic neurons, we performed fear conditioning tests. It appeared that fear learning deficit of Chat-Mecp2-/y mice was rescued towards the end of training with MeCP2 restoration in the cholinergic neurons of NAc, but not medial septum (MS) (Figure 2—figure supplement 2). Consistently, in the context and tone fear retrieval tests, although the freezing level was not comparable to that of the AAV/GFP-injected ChatCre mice, Chat-Mecp2-/y mice injected with the AAV/Mecp2 virus showed a significant enhancement (Figure 2C,D). In contrast, MeCP2 restoration in the cholinergic neurons of MS, which has been reported to mediate sensory induced aversion (Zhang et al., 2018), had no effect on fear regulation in Chat-Mecp2-/y mice (Figure 2E,F).

Figure 2. Restoration of MeCP2 in NAc rather than Cholinergic Neurons of Medial Septum Rescued Fear Deficits in Chat-Mecp2-/y Mice.

(A) Representative fluorescence images showing NAc sections of Chat-Mecp2-/y-AAV/GFP and Chat-Mecp2-/y-AAV/Mecp2 stained for DAPI, MeCP2, and ChAT. (B) Percentage of ChAT-positive cells in NAc co-expressing overexpression virus (left) and efficiency of MeCP2 restoration in GFP-positive neurons (right) in Chat-Mecp2-/y-AAV/Mecp2 mice. n = 10 mice. (C–F) Fear conditioning test was conducted three weeks after microinjection in NAc (C, D) or MS (E, F). P-values were calculated by one-way analysis of variance (ANOVA) with Bonferroni’s multiple comparisons test. F (2, 27)=7.304, p=0.0029 for (C). F (2, 27)=8.469, p=0.0014 for (D). F (2, 31)=14.52, p<0.0001 for (E). F (2, 31)=8.261, p=0.0013 for (F). n = 11 (ChatCre-AAV/GFP in NAc), 9 (Chat-Mecp2-/y-AAV/GFP in NAc), 10 (Chat-Mecp2-/y-AAV/Mecp2 in NAc); 15 (ChatCre-AAV/GFP in MS), 8 (Chat-Mecp2-/y-AAV/GFP in MS), 11 (Chat-Mecp2-/y-AAV/Mecp2 in MS). Data are means ± SEM. *p<0.05, **p<0.01, ***p<0.001, NS means no significance.

Figure 2—source data 1. Statistical reporting of Figure 2.

Figure 2.

Figure 2—figure supplement 1. Systemic Delivery of Various AAV Vectors into NAc, Related to Figures 245.

Figure 2—figure supplement 1.

(A) Diagram of virus injection into NAc (right) of ChatCre mice and confocal image of AAV/GFP vector-injected NAc slice demonstrating colocalization of GFP expression with ChAT antibody, co-stained with DAPI (left). (B) Confocal image of AAV/Mecp2 vector-injected NAc slice demonstrating colocalization of GFP expression with ChAT antibody, co-stained with DAPI. (C) Confocal image of AAV/NpHR and AAV/α2 RNAi vector-injected NAc slices demonstrating colocalization of mCherry expression with GFP expression, co-stained with DAPI.
Figure 2—figure supplement 2. Restoration of MeCP2 in NAc rather than Cholinergic neurons of MS Rescued Fear deficit at the last trial of learning, Related to Figure 2.

Figure 2—figure supplement 2.

(A, B) Fear conditioning test was conducted three weeks after microinjection in NAc (A) or MS (B). P-values were calculated by one-way analysis of variance (ANOVA) with Bonferroni’s multiple comparisons test. F (2, 27)=5.929, p=0.0073 for Trial four during fear learning in (A). Bonferroni’s multiple comparisons test: P (ChatCre-AAV/GFP in NAc vs. Chat-Mecp2-/y-AAV/GFP in NAc)=0.0060, P (Chat-Mecp2-/y-AAV/GFP in NAc vs. Chat-Mecp2-/y-AAV/Mecp2 in NAc)=0.0241. F (2, 31)=4.258, p=0.0232 for Trial four during fear learning in (B). Bonferroni’s multiple comparisons test: P (ChatCre-AAV/GFP in MS vs. Chat-Mecp2-/y-AAV/GFP in MS)=0.0461, P (Chat-Mecp2-/y-AAV/GFP in MS vs. Chat-Mecp2-/y-AAV/Mecp2 in MS)>0.9999. n = 11 (ChatCre-AAV/GFP in NAc), 9 (Chat-Mecp2-/y-AAV/GFP in NAc), 10 (Chat-Mecp2-/y-AAV/Mecp2 in NAc); 15 (ChatCre-AAV/GFP in MS), 8 (Chat-Mecp2-/y-AAV/GFP in MS), 11 (Chat-Mecp2-/y-AAV/Mecp2 in MS). Data are means ± SEM. *p<0.05, NS means no significance.

Taken together, these regional restoration results indicate that impaired fear learning in Chat-Mecp2-/y mice arises, at least in part, from the lack of MeCP2 expression in NAc cholinergic interneurons.

Spontaneous firing of cholinergic interneurons decreased via elevated expression of GABAA α2 receptors in Chat-Mecp2-/ymice

We next sought to uncover the cellular mechanisms underlying impaired fear learning in Chat-Mecp2-/y mice. First, we measured the spontaneous firing frequency of cholinergic interneurons in brain slices, as NAc cholinergic interneurons are considered tonic firing neurons (Zahar and Morris, 2014). The spontaneous spiking rate of NAc cholinergic interneurons was significantly decreased in Chat-Mecp2-/y mice in both cell-attached (Figure 3A,B) and whole-cell configurations (Figure 3C,D). We also evaluated the spontaneous firing rate and found a significant increase in Chat-Mecp2-/y mice with MeCP2/AAV expression compared with GFP/AAV expression (Figure 3E,F). According to these results, we found that the fear learning deficits in Chat-Mecp2-/y mice could be attributed to decreased tonic firing in NAc cholinergic interneurons.

Figure 3. Spontaneous Firing of Cholinergic Interneurons Decreased via Elevated Expression of GABAA α2 Receptors in Chat-Mecp2-/y Mice.

(A, B) Example traces of spontaneous spiking (A) or averaged frequency (B) measured in a cell-attached configuration from NAc cholinergic interneurons. P-values were calculated by one-way analysis of variance (ANOVA) with Bonferroni’s multiple comparisons test. F (2, 41)=13.93, p<0.0001. n = 18 neurons from three mice (ChatCre), 13 neurons from three mice (Mecp2flox/y), 13 neurons from five mice (Chat-Mecp2-/y). (C, D) Example traces of spontaneous spiking (C) or averaged frequency (D) measured in a whole-cell configuration from NAc cholinergic interneurons. P-values were calculated by one-way ANOVA with Bonferroni’s multiple comparisons test. F (2, 34)=5.336, p=0.0096. n = 16 neurons from three mice (ChatCre), 13 neurons from four mice (Mecp2flox/y), 8 neurons from five mice (Chat-Mecp2-/y). (E, F) Example traces of spontaneous spiking (E) or averaged frequency (F) measured in a whole-cell configuration from NAc neurons infected by AAV-GFP or AAV/Mecp2 for indicated genotype. Data are means ± SEM. P-values were calculated by one-way ANOVA with Tukey’s multiple comparisons test. F (2, 27)=6.201, p=0.0061. n = 9 neurons from three mice (ChatCre-AAV/GFP), 9 neurons from three mice (Chat-Mecp2-/y-AAV/GFP), 12 neurons from three mice (Chat-Mecp2-/y-AAV/Mecp2). (G, H) Example mIPSC traces (G) measured in whole-cell configuration from NAc cholinergic interneurons. (H) Cumulative distribution of mIPSC amplitude of NAc cholinergic interneurons. P-values were calculated by one-way ANOVA with Bonferroni's multiple comparisons test. F (2, 39)=15.46, p<0.0001. n = 12 neurons from four mice (ChatCre), 14 neurons from four mice (Mecp2flox/y), 16 neurons from four mice (Chat-Mecp2-/y). (I) Confocal images showing NAc sections stained for PV, ChAT, GABAA α2 receptor, and DAPI. Bar graph showing percentage of ChAT or PV-positive cells co-expressing GABAA α2 receptor in wild-type (WT) mice. n = 8 sections from two mice. (J) Immunoblotting of GABAA α2 receptor in NAc extracts prepared from ChatCre and Chat-Mecp2-/y mice. Each lane was loaded with 40 μg of protein, with GAPDH as loading control, and normalized to ChatCre levels. P-values were calculated by two-tailed unpaired t-test. t = 2.153, df = 28, p=0.0401. n = 15 mice per group. (K) Representative images of NAc slices from ChatCre and ChAT-Mecp2-/y mice. Statistically integrated immunofluorescence data normalized to ChatCre levels. P-values were calculated by two-tailed unpaired t-test. t = 2.986, df = 14, p=0.0098. n = 7–9 sections from two mice per group. (L, M) Example traces (L) and statistical results (M) of spontaneous spiking recorded from cholinergic interneurons in NAc of different groups. P-values were calculated by two-tailed unpaired t-test. t = 3.977, df = 25, p=0.0005. n = 14 neurons from four mice for ACSF, n = 13 neurons from four mice for L-838,417. L-838,417: an α2-subunit-selecive selective positive allosteric modulator of GABAA receptors. Data are means ± SEM. *p<0.05, **p<0.01, ***p<0.001, NS means no significance.

Figure 3—source data 1. Statistical reporting of Figure 3.

Figure 3.

Figure 3—figure supplement 1. Chat-Mecp2-/y Mice Exhibited No Statistical Difference in Intrinsic Properties in NAc Cholinergic Interneurons, Related to Figure 3.

Figure 3—figure supplement 1.

(A–D) Quantitative analysis of resting membrane potential (RMP), membrane time constant (Tau), input resistance (Rin), and membrane capacitance (Cm) of cholinergic interneurons from NAc slices. P-values were calculated by one-way analysis of variance (ANOVA) with Bonferroni’s multiple comparisons test. F (2, 32)=0.005866, p=0.9942 for RMP. F (2, 32)=0.3762, p=0.6894 for Tau. F (2, 32)=0.3748, p=0.6904 for Cm. F (2, 32)=1.809, p=0.1801 for Rin. n = 13 neurons from four mice (ChatCre), 11 neurons from three mice (Mecp2flox/y), 11 neurons from three mice (Chat-Mecp2-/y). (E–H) Quantitative analysis of threshold, amplitude, half width, and after-hyperpolarization potential (ahp) for a single spike of cholinergic interneurons from NAc slices. P-values were calculated by one-way ANOVA with Bonferroni’s multiple comparisons test. F (2, 36)=1.222, p=0.3066 for threshold. F (2, 36)=0.7935, p=0.4600 for amplitude. F (2, 36)=0.1402, p=0.8697 for half width. F (2, 36)=0.1137, p=0.8929 for ahp. n = 15 neurons from four mice (ChatCre), 9 neurons from three mice (Mecp2flox/y), 15 neurons from five mice (Chat-Mecp2-/y). Data are means ± SEM. NS means no significance.
Figure 3—figure supplement 2. Depletion of MeCP2 Did Not Affect mIPSC Frequency of Cholinergic Interneurons, with Limited Expression of GABAA Receptor α1 Subunits in Cholinergic Interneurons within NAc, Related to Figure 3.

Figure 3—figure supplement 2.

(A) Cumulative distribution of mIPSC inter-event interval and average frequency of NAc cholinergic interneurons. P-values were calculated by one-way analysis of variance (ANOVA) with Bonferroni’s multiple comparisons test. F (2, 39)=1.535, p=0.2282. n = 12 neurons from four mice (ChatCre), 14 neurons from four mice (Mecp2flox/y), 16 neurons from four mice (Chat-Mecp2-/y). (B) Fluorescence images showing NAc sections stained for the PV, ChAT, GABAA receptor α1, and DAPI. (C) Immunoblotting of GABAA receptor α1 in NAc extracts prepared from ChatCre and Chat-Mecp2-/y mice. Each lane was loaded with 40 μg of protein, with GAPDH as loading control, and normalized to ChatCre levels. Data are means ± SEM. P-values were calculated by two-tailed unpaired t-test. t = 0.3411, df = 12, p=0.7390. n = 7 for ChatCre mice, seven for Chat-Mecp2-/y mice. (D Example traces and statistical results of spontaneous spiking recorded from cholinergic interneurons in NAc of Chat-Mecp2-/y mice. P-values were calculated by two-tailed unpaired t-test. t = 2.496, df = 19, p=0.0219. n = 11 neurons from three mice for ACSF, n = 10 neurons from three mice for L-838,417. (E) Example sIPSC traces and statistical results of amplitude and frequency recorded from cholinergic interneurons in NAc of ChatCre mice. P-values were calculated by two-tailed unpaired t-test. t = 2.688, df = 20, p=0.0141 for amplitude. t = 2.099, df = 20, p=0.0488 for frequency. n = 11 neurons from three mice for each group. (F) Example sIPSC traces and statistical results of amplitude and frequency recorded from cholinergic interneurons in NAc of Chat-Mecp2-/y mice. P-values were calculated by two-tailed unpaired t-test. t = 2.108, df = 18, p=0.0493 for amplitude. t = 3.536, df = 18, p=0.0024 for frequency. n = 10 neurons from three mice for each group. Data are means ± SEM. NS means no significance.

Changes in spontaneous activity can be attributed to changes in either intrinsic properties or synaptic inputs (Cheng et al., 2019; Brown et al., 2012). Thus, we first measured the intrinsic properties of the cholinergic interneurons in the NAc and found no significant differences between Chat-Mecp2-/y and control mice (Figure 3—figure supplement 1). To examine the synaptic inputs of the cholinergic interneurons, we measured miniature inhibitory postsynaptic currents (mIPSCs). Although the frequency of mIPSCs was not altered in the NAc cholinergic interneurons of Chat-Mecp2-/y mice, their amplitude was significantly increased compared to that in control mice, indicating abnormal changes in postsynaptic connections in the cholinergic interneurons (Figure 3G,H; Figure 3—figure supplement 2A). Consistent with previous studies (Bennett and Wilson, 1999), our whole-cell voltage-clamp recordings showed that miniature excitatory postsynaptic currents (mEPSCs) were rarely recorded in the cholinergic interneurons (mEPSC frequency <0.1 Hz, data not shown).

The GABAA receptor is a heteropentameric ligand-gated chloride channel that mediates major inhibitory transmission in the brain (Farrant and Nusser, 2005). Receptors with different subunits are distributed in different neurons and play distinct roles in current responses (Lavoie et al., 1997). Surprisingly, we found that approximately 70% of ChAT-positive neurons expressed detectable levels of α2 subunits in the NAc (Figure 3I). In contrast, there was little expression of α1 subunits in the NAc cholinergic interneurons (Figure 3—figure supplement 2B). To determine whether the synaptic phenotypes in Chat-Mecp2-/y mice could be ascribed to aberrant GABAA receptor expression, we assessed the expression of α subunits in the NAc by western blot analysis. We found that α2 was increased in Chat-Mecp2-/y mice but α1 was unchanged (Figure 3J; Figure 3—figure supplement 2C). Furthermore, immunohistochemistry results showed a significant increase in α2 expression specifically in the cholinergic interneurons of Chat-Mecp2-/y mice compared to those of ChatCre mice (Figure 3K).

We next investigated the role of α2-containing GABAA receptors in regulating the spiking of cholinergic interneurons in NAc. L-838,417, an α2-subunit-selecive positive allosteric modulator of GABAA receptors, has no efficacy in α1 subtypes. Potentiating the α2-GABAA receptors with L-838,417 (2 μM) in bath solution significantly decreased the firing frequency of cholinergic interneurons in NAc slices from both control (Figure 3L,M) and Chat-Mecp2-/y mice (Figure 3—figure supplement 2D). Further, we also compared the effect of L-838,417 on GABAergic current and found that both the frequency and amplitude of sIPSC have been increased after treatment (Figure 3—figure supplement 2E,F).

Together, these results indicate that MeCP2 deficiency in cholinergic interneurons enhances inhibitory synaptic transmission, which could be ascribed to increased α2-GABAA expression.

Activation of NAc cholinergic interneurons in Chat-Mecp2-/ymice rescued fear deficits

We further examined whether enhancing the spontaneous firing of NAc cholinergic interneurons is sufficient to improve freezing response in Chat-Mecp2-/y mice. We used AAV-DIO-hM3Dq-mCherry (AAV/hM3Dq), an excitatory designer receptor exclusively activated by designer drugs (Figure 4A). Electrophysiological analysis of NAc slices confirmed that 1 μM clozapine-N-oxide (CNO) activated spiking in hM3Dq-expressed NAc cholinergic interneurons (Figure 4—figure supplement 1A,B). We then examined the effect of CNO (1 mg/kg) administration in Chat-Mecp2-/y mice with AAV/hM3Dq delivered to NAc cholinergic interneurons. Activation of NAc cholinergic interneurons significantly increased the freezing level of Chat-Mecp2-/y mice in the training process (Figure 4—figure supplement 1C), as well as the context and tone fear memory retrieval process (Figure 4B,C). We manipulated the NAc cholinergic interneurons only in fear learning, with the fear memory test conducted without additional manipulations. To confirm these behavioral results, we selectively activated cholinergic interneurons by infusing AAV-DIO-ChR2-EYFP (AAV/ChR2) into the NAc of Chat-Mecp2-/y mice and inserted an optical fiber above it bilaterally (Figure 4D). Electrophysiological recordings of NAc cholinergic interneurons reliably revealed one-to-one, photo-stimulation locked action potential firing at frequencies up to 10 Hz (Figure 4—figure supplement 1D). We found that optogenetic activation of cholinergic interneurons (8 Hz) only during fear learning also rescued fear deficits in Chat-Mecp2-/y mice (Figure 4E,F and Figure 4—figure supplement 1E). We also confirmed that activation of NAc cholinergic neurons had no effect on freezing in the absence of shock delivery (Figure 4—figure supplement 1F–H).

Figure 4. Activation of NAc Cholinergic Interneurons Rescued Fear Deficits in Chat-Mecp2-/y Mice.

(A) Up: Schematic of AAV/hM3Dq viral construct. Down: Confocal image of injected NAc slice demonstrating colocalization of mCherry expression with ChAT antibody, co-stained with DAPI. (B, C) Fear retrieval was measured by retrieval process in fear conditioning test. P-values were calculated by one-way analysis of variance (ANOVA) with Bonferroni’s multiple comparisons test. F (2, 26)=7.801, p=0.0022 for (B). F (2, 26)=7.583, p=0.0025 for (C). n = 10 (ChatCre-AAV/mCherry), 10 (Chat-Mecp2-/y-AAV/mCherry), 9 (Chat-Mecp2-/y-AAV/hM3Dq). (D) Up: Schematic of AAV/ChR2 viral construct. Down: Confocal image of AAV/ChR2 vector-injected NAc slice demonstrating colocalization of GFP expression with ChAT antibody, co-stained with DAPI. (E, F) Fear was measured by retrieval process in fear conditioning test. P-values were calculated by one-way ANOVA with Bonferroni’s multiple comparisons test. F (2, 28)=10.50, p=0.0004 for (E). F (2, 28)=6.356, p=0.0053 for (F). n = 8 (ChatCre-AAV/mCherry), 14 (Chat-Mecp2-/y-AAV/mCherry), 9 (Chat-Mecp2-/y-AAV/ChR2). Data are means ± SEM. *p<0.05, **p<0.01, ***p<0.001. (See also Figure 2—figure supplement 1).

Figure 4—source data 1. Statistical reporting of Figure 4.

Figure 4.

Figure 4—figure supplement 1. Activation of NAc Cholinergic Interneurons Rescued Fear Deficits in Chat-Mecp2-/y Mice, Related to Figure 4.

Figure 4—figure supplement 1.

(A, B) Representative spontaneous firing (A) and summary histogram (B) of hM3Dq-mCherry expressing ChAT neurons in Chat-Mecp2-/y mice before (red) and after (gray) CNO treatment. P-values were calculated by two-tailed paired t-test. t = 4.442, df = 5, p=0.0067. n = 6 neurons from three mice. (C) Fear conditioning test was conducted 30 min after CNO injection. P-values were calculated by one-way analysis of variance (ANOVA) with Bonferroni’s multiple comparisons test. F (2, 26)=5.245, p=0.0122 for Trial four during fear learning. Bonferroni’s multiple comparisons test: P (ChatCre-AAV/mCherry vs. Chat-Mecp2-/y-AAV/mCherry)=0.0072, P (Chat-Mecp2-/y-AAV/mCherry vs. Chat-Mecp2-/y-AAV/hM3Dq)=0.1148. n = 10 (ChatCre-AAV/mCherry), 10 (Chat-Mecp2-/y-AAV/mCherry), 9 (Chat-Mecp2-/y-AAV/hM3Dq). (D) Up: Consecutive action potentials in AAV/ChR2-affected cholinergic interneurons evoked by a 470 nm pulse train (5 ms pulse width; 8 Hz). Down: Average success probability for generating action potentials in AAV/ChR2-affected cholinergic interneurons at different stimulation frequencies. n = 8 neurons from three mice. (E) Fear conditioning test was conducted with 8 Hz blue light during the training. P-values were calculated by one-way analysis of variance (ANOVA) with Bonferroni’s multiple comparisons test. F (2, 28)=4.160, p=0.0262 for Trial four during fear learning. Bonferroni’s multiple comparisons test: P (ChatCre-AAV/mCherry vs. Chat-Mecp2-/y-AAV/mCherry)=0.0290, P (Chat-Mecp2-/y-AAV/mCherry vs. Chat-Mecp2-/y-AAV/ChR2)=0.0846. n = 8 (ChatCre-AAV/mCherry), 14 (Chat-Mecp2-/y-AAV/mCherry), 9 (Chat-Mecp2-/y-AAV/ChR2). (F, G) Freezing time was measured in chamber for 2 min without shock. P-values were calculated by one-way analysis of variance (ANOVA) with Bonferroni’s multiple comparisons test. F (2, 26)=1.541, p=0.2332, n = 10 (ChatCre-AAV/mCherry), 10 (Chat-Mecp2-/y-AAV/mCherry), 9 (Chat-Mecp2-/y-AAV/hM3Dq) for F; F (2, 28)=0.1714, p=0.8434, n = 8 (ChatCre-AAV/mCherry), 14 (Chat-Mecp2-/y-AAV/mCherry), 9 (Chat-Mecp2-/y-AAV/ChR2) for G. (H) Locomotor activity was measured in open field test after injection of CNO. P-values were calculated by one-way analysis of variance (ANOVA) with Bonferroni’s multiple comparisons test. F (2, 21)=0.1139, p=0.8929. n = 6 (ChatCre-AAV/mCherry), 8 (Chat-Mecp2-/y-AAV/mCherry), 9 (Chat-Mecp2-/y-AAV/hM3Dq). Data are means ± SEM. *p<0.05, **p<0.01, NS means no significance.

These results indicate that activation of the decreased activity in NAc cholinergic interneurons could rescue the fear learning deficits in Chat-Mecp2-/y mice.

Inhibition of NAc cholinergic interneurons resulted in fear deficits

To investigate if NAc cholinergic neurons play a causal role in fear encoding, we selectively inhibited NAc cholinergic interneurons in vivo by delivering the AAV-DIO-hM4Di-mCherry vector into the NAc of ChatCre mice (Figure 5A). Application of CNO before fear conditioning significantly decreased context and tone fear responses during the retrieval process (Figure 5B,C). As a key region of emotional valence encoding, the NAc is composed of two subregions, that is the shell and core, which have different anatomical structure and function (Castro and Bruchas, 2019; de Jong et al., 2019). We wondered if these two subregions play different roles in fear regulation. As such, we used optogenetic manipulation to inhibit the activity of cholinergic interneurons in the NAc precisely. We injected AAV-FLEX-NpHR-EYFP (AAV/NpHR), an AAV-DIO vector expressing halorhodopsin fused with EYFP, and inserted optical fibers above the NAc core, the medial shell, and ventral medial shell bilaterally into ChatCre mice separately (Figure 5—figure supplement 1). Inhibition of cholinergic neurons in core or shell has similar effect on context/tone fear. However, if we only inhibit cholinergic neurons in NAc medial shell, only tone fear was impaired, with context fear intact, suggesting the heterogeneity within NAc shell (Figure 5D,E).

Figure 5. Inhibition of NAc Cholinergic Interneurons in ChatCre Mice Mimicked Fear Deficits in Chat-Mecp2-/y Mice.

(A) Schematic of AAV/hM4Di viral construct. Confocal image of injected NAc slice demonstrating colocalization of mCherry expression with ChAT antibody, co-stained with DAPI. (B, C) Fear retrieval was measured by retrieval process in fear conditioning test. P-values were calculated by two-tailed unpaired t-test. t = 3.204, df = 32, p=0.0031 for (B). t = 3.572, df = 32, p=0.0011 for (C). n = 16 (ChatCre-AAV/mCherry), 18 (ChatCre-AAV/hM4Di). (D, E) Fear retrieval was measured by retrieval process in fear conditioning test with opto-inhibition of cholinergic neurons in different NAc subregions. P-values were calculated by two-tailed unpaired t-test. t = 2.530, df = 11, p=0.0280 comparison of NpHR (NAc) effect in context fear. t = 3.662, df = 13, p=0.0029 comparison of NpHR (NAc core) effect in context fear. t = 1.179, df = 13, p=0.2593 comparison of NpHR (NAc medial shell) effect in context fear. t = 5.140, df = 13, p=0.0002 comparison of NpHR (NAc ventral medial shell) effect in context fear. t = 3.308, df = 11, p=0.0113 comparison of NpHR (NAc) effect in tone fear. t = 2.600, df = 13, p=0.0220 comparison of NpHR (NAc core) effect in tone fear. t = 4.181, df = 13, p=0.0011 comparison of NpHR (NAc medial shell) effect in tone fear. t = 3.026, df = 13, p=0.0097 comparison of NpHR (NAc ventral medial shell) effect in tone fear. n = 7 (ChatCre-AAV/GFP in NAc), 6 (ChatCre-AAV/NpHR in NAc), 8 (ChatCre-AAV/NpHR in NAc core), 8 (ChatCre-AAV/NpHR in NAc medial shell), 8 (ChatCre-AAV/NpHR in NAc ventral medial shell). (F) Schematic of AAV/NpHR viral construct. Confocal image of injected NAc slice demonstrating colocalization of mCherry expression with ChAT antibody, co-stained with DAPI. (G, H) Example traces (G) and statistical results (H) of spontaneous spiking recorded from cholinergic interneurons in NAc of different groups. P-values were calculated by one-way ANOVA with Newman-keuls multiple comparison test. F (3, 40)=33.06, p<0.0001. n = 13 neurons from three mice (ChatCre-AAV/Sham), 10 neurons from three mice (Chat-Mecp2-/y-AAV/Sham), 9 neurons from three mice (Chat-Mecp2-/y-AAV/α2RNAi), 12 neurons from four mice (Chat-Mecp2-/y-AAV/α2RNAi and AAV/NpHR). (I, J) Fear retrieval was measured by retrieval process in fear conditioning test. P-values were calculated by one-way ANOVA with Newman-keuls multiple comparisons test. F (3, 44)=6.066, p=0.0015 in (I). F (3, 44)=5.426, p=0.0029 in (J). n = 8 mice (ChatCre-AAV/Sham), 10 mice (Chat-Mecp2-/y-AAV/Sham), 21 mice (Chat-Mecp2-/y-AAV/α2RNAi), nine mice (Chat-Mecp2-/y-AAV/α2RNAi and AAV/NpHR). (K) Locomotor activity (15 min) was measured in open field test. P-values were calculated by one-way ANOVA with Newman-keuls multiple comparisons test. F (3, 40)=0.9904, p=0.4071. n = 7 (ChatCre-AAV/Sham), 8 (Chat-Mecp2-/y-AAV/Sham), 20 (Chat-Mecp2-/y-AAV/α2RNAi), nine mice (Chat-Mecp2-/y-AAV/α2RNAi and AAV/NpHR). Data are means ± SEM. *p<0.05, **p<0.01, ***p<0.001, NS means no significance. (See also Figure 2—figure supplement 1).

Figure 5—source data 1. Statistical reporting of Figure 5.

Figure 5.

Figure 5—figure supplement 1. Inhibition of NAc Cholinergic Interneurons in ChatCre Mice, Related to Figure 5.

Figure 5—figure supplement 1.

Confocal image of injected NAc slice demonstrating localization of NpHR expression and fiber position in NAc core (A), NAc ventral medial shell (B), and NAc medial shell (C).

Thus, the above findings imply that inhibition of NAc cholinergic interneurons results in fear deficits.

Down-regulation of GABAA α2 receptors in NAc cholinergic interneurons in Chat-Mecp2-/ymice rescued fear deficits

To determine whether down-regulation of α2-GABAA receptors in the NAc can reverse impaired fear encoding in Chat-Mecp2-/y mice, we knocked down α2-GABAA receptors via RNA interference (RNAi). The AAV-FLEX-siRNA-GFP (AAV/α2RNAi) virus was delivered bilaterally into the NAc of Chat-Mecp2-/y mice (Figure 6A). We first verified virus efficiency by slice recordings. In the NAc of Chat-Mecp2-/y mice, neurons infected by AAV/α2RNAi showed significantly decreased mIPSC amplitude compared to the scrambled controls (AAV/sham) (Figure 6B,C), but no changes in mIPSC frequency (Figure 6—figure supplement 1). Immunohistochemical analysis also revealed AAV/α2RNAi specific infection in the cholinergic interneurons of the NAc and ~50% knockdown efficiency of α2-GABAA receptors in the cholinergic interneurons (Figure 6D,E). Furthermore, we found that down-regulating α2-GABAA receptors in the NAc of Chat-Mecp2-/y mice rescued the decreased spontaneous firing rates of NAc cholinergic interneurons (Figure 5G,H). Functionally, the freezing response in the context and tone fear retrieval period was markedly improved in Chat-Mecp2-/y mice infected with AAV/α2RNAi compared with the AAV/sham group (Figure 5I,J). Locomotor activity was not significantly changed, suggesting that the freezing behavior was not due to motor defects (Figure 5K). Thus, according to these results, down-regulation of α2-GABAA receptors in the NAc of Chat-Mecp2-/y mice can rescue the decreased spontaneous firing rates of NAc cholinergic interneurons as well as fear deficits.

Figure 6. Manipulation of α2-GABAA Receptors in NAc Mimicked Fear Deficits in Chat-Mecp2-/y Mice.

(A) Schematic of AAV/RNAi viral construct. Confocal image of injected NAc slice demonstrating colocalization of GFP expression with ChAT antibody, co-stained with DAPI. (B, C) mIPSCs of AAV/RNAi-infected NAc neurons from Chat-Mecp2-/y mice were rescued. (B) Examples of mIPSC traces. (C) Cumulative distribution of mIPSC amplitude of NAc neurons infected by AAV-Sham or AAV/RNAi. P-values were calculated by one-way analysis of variance (ANOVA) with Bonferroni’s multiple comparisons test. F (2, 39)=5.816, p=0.0062. n = 14 neurons from four mice for each group. (D) Representative images of NAc slices from Chat-Mecp2-/y mice injected with AAV/GFP or AAV/RNAi. (E) Statistically integrated immunofluorescence data of α2-GABAA receptors normalized to AAV/GFP levels. P-values were calculated by two-tailed unpaired t-test. t = 2.985, df = 39, p=0.0049. n = 27 neurons from three mice (AAV/RNAi), 14 neurons from three mice (AAV/Sham). (F) Left: Schematic of cannula implantation. Right: Infusion sites of drugs, stained with DAPI. (G, H) Fear deficit was measured by retrieval process in fear conditioning test 20 min after drug application. P-values were calculated by two-tailed unpaired t-test. t = 2.542, df = 23, p=0.0182 for (E). t = 3.609, df = 23, p=0.0015 for (F). n = 14 mice for ACSF, n = 11 mice for L-838,417. Data are means ± SEM. *p<0.05, **p<0.01.

Figure 6—source data 1. Statistical reporting of Figure 6.

Figure 6.

Figure 6—figure supplement 1. Knockdown of α2-GABAA Receptors in Cholinergic Interneurons Did Not Affect mIPSC Frequency in Cholinergic Interneurons, Related to Figure 6.

Figure 6—figure supplement 1.

Cumulative distribution of mIPSC amplitude in NAc neurons infected by AAV-Sham or AAV/RNAi. P-values were calculated by one-way analysis of variance (ANOVA) with Bonferroni’s multiple comparisons test. F (2, 39)=1.066, p=0.3541. n = 14 neurons from four mice for each group. NS means no significance.
Figure 6—figure supplement 2. Retrograde tracing from NAc cholinergic neurons.

Figure 6—figure supplement 2.

(A) Sequential injections of AAV-FLEX-TVA-GFP, AAV-FLEX-Rabies-glycoprotein and G-deleted EnA-rabies-mCh into NAc of a ChatCre mouse labeled starter cells (yellow). (B, C) Transsynaptic retrograde labeling neurons in the BLA (B) and (vHPC). BLA: basolateral amygdala. CeA: central nucleus of the amygdala. vHIP: ventral hippocampus.

We next used mixtures of AAV/α2RNAi and AAV/NpHR to investigate whether the recuperation effect of AAV/α2RNAi in fear encoding was mediated through the spiking of cholinergic interneurons (Figure 5F; Figure 2—figure supplement 1C). We verified functionality with slice recordings and found that NpHR-mediated hyperpolarization efficiently blocked the spontaneous firing rates of cholinergic interneurons (Figure 5G,H). Inhibiting the spiking of cholinergic interneurons with yellow light (593 nm) only during the learning phase abolished the rescue effects of AAV/RNAi in Chat-Mecp2-/y mice (Figure 5I,J) without affecting locomotion (Figure 5K). These results demonstrate that the rescue of fear learning by down-regulation of NAc α2-GABAA receptors requires the modulation of cholinergic activity.

The above findings suggest that down-regulation of GABAA α2 receptors in NAc cholinergic interneurons of Chat-Mecp2-/y mice can rescue the decreased tonic firing rate of cholinergic interneurons and fear deficits in these mice.

Based on our evidence that α2-GABAA receptors increase in cholinergic interneurons of Chat-Mecp2-/y mice, we hypothesized that α2-GABAA receptors are a potential target for fear learning regulation. To simulate enhanced α2-specific inhibitory transmission in Chat-Mecp2-/y mice, we injected L-838,417 into the bilateral NAc of wild-type mice 30 min prior to the training period of fear conditioning only (Figure 6F). In the retrieval sessions, identical scenery or tone elicited significantly decreased freezing levels in the L-838,417 group (Figure 6G,H), suggesting that activation of α2-containing GABAA receptors in the NAc was sufficient to dampen the spiking of cholinergic interneurons and impair fear behavior.

Discussion

Here, we observed robust fear learning deficits and reduction in cholinergic interneuron activity in the NAc of Chat-Mecp2-/y mice, which could be attributed to an elevation in α2-containing GABAA receptors. Furthermore, with various manipulations of cholinergic interneurons in the NAc, fear learning could be regulated bi-directionally. Taken together, our study adds to growing evidence of the involvement of MeCP2 and NAc in fear regulation.

Deficiency of MeCP2 in specific neuron types or regions results in RTT-like phenotypes in mice (Fyffe et al., 2008; Guy et al., 2001; Zhang et al., 2016b). For example, PV-Mecp2-/y, CAMKII-Mecp2-/y, and MeCP2 region-specific deletion from the basolateral amygdala (BLA) results in anxiety-like behavior and impaired learning ability (Adachi et al., 2009; Chen et al., 2001; Ito-Ishida et al., 2015; Gemelli et al., 2006). Furthermore, Mecp2308/y and Viaat-Mecp2-/y mice almost recapitulate the entire spectrum of RTT features, including motor dysfunction, seizure, and stereotyped behaviors (Chao et al., 2010; Shahbazian et al., 2002; Moretti et al., 2006). Here, we found that dysfunction of NAc cholinergic interneurons accounted for the impaired context-dependent and cue-related fear learning in Chat-Mecp2-/y mice. However, these results are inconsistent with recent findings, which suggest that Chat-Mecp2-/y mice do not exhibit impaired fear conditioning (Ballinger et al., 2019). One possible explanation for this difference may be the use of larger footshock (2 s, 1 mA), which could render a strong fear response in over-trained mice, thereby obscuring the effect of Mecp2 deletion in cholinergic neurons. Another possibility could be the age difference. Ballinger et al. conducted fear conditioning test when mice were 21 weeks old. However, the mice we used throughout experiments were 9 to 12 weeks. Since RTT is a neurodevelopmental disorder, there is high possibility that age difference of mice between two studies lead to distinct results. Interestingly, Mecp2308/y mice only display context-dependent fear memory deficits (Moretti et al., 2006); whereas, mice with PV-Mecp2-/y, CAMKII-Mecp2-/y, and MeCP2 region-specific deletions from the BLA only show cue-related fear memory deficits (Ito-Ishida et al., 2015; Adachi et al., 2009; Gemelli et al., 2006). Given that these observations of distinct behaviors manifesting in Mecp2-conditioned knockout mice can be attributed to different neuron types located in different brain regions, we proposed that conditional deletion of Mecp2 from specific neurons in specific brain regions will help dissociate a broad spectrum of RTT phenotypes. To be noted, we used male mice throughout this study. Considering that Mecp2 gene is located on the X chromosome, female mice are typically mosaic at the cellular level for MeCP2 expression, which may contribute to phenotype variability. Thus, our results with males may not pertain to females.

The ability to associate neutral environmental factors with aversive stimuli is of pivotal importance for survival, and perturbations of associative fear learning may underlie a wide variety of psychiatric disorders (Adolphs, 2013; Tovote et al., 2015). The amygdala has been emphasized as an essential component in the network that encodes fear (Adolphs, 2013; Johansen et al., 2010; Maren and Quirk, 2004; Paton et al., 2006; Reijmers et al., 2007; Janak and Tye, 2015; Yu et al., 2017; Li et al., 2013). Furthermore, evidence on the functions and molecular mechanisms of extra-amygdala brain regions regulating fear learning has recently emerged (Dong et al., 2019; Groessl et al., 2018; Zhang et al., 2016a). Nevertheless, whether the NAc, a reward and aversion center in the brain, participates in fear has not been clearly ascertained (Floresco, 2015; Hu, 2016; Reynolds and Berridge, 2008; Russo and Nestler, 2013). Here, our evidence indicates that NAc cholinergic interneurons are important to fear learning regardless of whether context or tone was tested. The most probable explanation could be that NAc CIN receives converging input from both HPC and BLA, thus participating in both context and tone fear regulation (Figure 6—figure supplement 2). In particular, the function of BLA→NAc circuit has been well reported in tone fear (Correia et al., 2016) and HPC→NAc circuit in contextual reward behavior (LeGates et al., 2018), indicating the involvement of NAc in both contextual and tone related behaviors. However, further study is necessary to dissect the function of the cholinergic neurons within BLA→NAc and HPC→NAc circuits.

Zhang et al. revealed that activating cholinergic neurons decreases fear response (Zhang et al., 2016a). This at first seems contradictory to our findings on the role of NAc CINs in promoting fear. However, there are differences in manipulation (ablation and activation with naïve mice vs. activation with knockout mice), which might contribute to different conclusion. Besides, habenular cholinergic neurons contribute to fear memory expression rather than fear encoding. Our study revealed the role of NAc CINs in fear encoding. Importantly, since these cholinergic neurons are in different brain regions, it is possible that different circuits they are involved and different molecular they express contributed to distinct roles in fear.

The NAc is known to be functionally heterogenous with respect to the regulation of positive and negative affect. Besides, a recent study also suggested the functional difference of CIN in NAc core and shell, with respect to depressive behaviors (Cheng et al., 2019). Thus, we got curious about the role of CIN within different NAc subregions in fear regulation. According to our result, inhibition of CIN in core and shell has similar effect on tone/context fear, with a slight difference in NAc medial shell, suggesting a potential heterogeneity within NAc shell. Since the anatomical and characteristics of CINs within shell and core are unknown, future studies are necessary in order to compare CINs in different NAc subregions.

NAc is a crucial brain region for emotional valence (Hu, 2016). Our pain threshold test suggested normal pain perception ability with conditional knockout mice, which excluded the possibility that MeCP2 in NAc CINs regulate overall emotion. Besides, our present data suggested that MeCP2 in NAc CINs regulate tone and contextual fear conditioning, both of which are conditioned fear. Importantly, conditioned and innate fear responses seem to be mediated, at least partially, through nonoverlapping circuits (Gross and Canteras, 2012), making it impossible to simply transfer our understanding of NAc CINs in conditioned fear to others. However, we believe it would be interesting to investigate their role in innate fear.

Cholinergic interneurons of the NAc are tonic firing interneurons that provide rich local innervation to MSNs (Higley et al., 2009), however, how they participate in fear learning is unclear. Previous studies exploring the causal relationship between striatal cholinergic interneurons and behaviors have relied on the complete ablation of cholinergic interneurons, which can cause reward-related behavioral deficits (Kitabatake et al., 2003; Xu et al., 2015). Accumulating evidence suggests that NAc cholinergic interneurons modulate their firing following exposure to cues associated with reward (Brown et al., 2012; Witten et al., 2010). Furthermore, reduced spontaneous activity of cholinergic interneurons can lead to depressive-like behaviors (Cheng et al., 2019). Here, we detected decreased firing rates of cholinergic interneurons in the NAc of Chat-Mecp2-/y mice, with activation of these neurons improving fear learning. It should be noted that light or pharmacological delivery to the NAc cholinergic interneurons was only conducted in fear learning, and the test of fear memory was conducted without additional manipulations as we speculated that ACh signaling is a requisite component in the learning process (Jiang et al., 2016). Thus, our results support the notion that cholinergic firing may be a modulator of associative fear learning. However, these results are inconsistent with conclusions arising from chronic ablation of these neurons (Kitabatake et al., 2003; Xu et al., 2015). One possible explanation could be that complete ablation of cholinergic interneurons may lead to an indirect compensatory effect, which may mask the direct effect of subtle variations in firing. As MSNs are the major neuron type and only output in the NAc, further studies are required to determine how cholinergic interneurons regulate MSN activity, further modulating fear learning.

We found that the amplitude of miniature inhibitory inputs was significantly increased in Chat-Mecp2-/y mice. In the brain, major inhibitory transmissions are mediated by the GABAA receptor, which is a ligand-gated chloride channel composed of two α, two β, and one γ subunit. Receptors with different α subunits play distinct roles in physiological and pharmacological functions (Fritschy and Mohler, 1995; Rudolph and Knoflach, 2011; Rudolph and Möhler, 2004; Vinkers et al., 2012). However, the distribution pattern of different α subunits within the NAc is largely unknown (Mitchell et al., 2018; Koo et al., 2014). Here, we showed that NAc cholinergic interneurons were more likely to express detectable α2-GABAA receptors than α1-GABAA receptors. However, whether inhibitory inputs through the α2-GABAA receptors are necessary or sufficient for the regulation of cholinergic firing within the NAc is unclear. Previous electrophysiological studies have suggested that blockade of GABAA receptors with bicuculline produces no obvious alteration in the firing rate of cholinergic interneurons (Bennett and Wilson, 1999). However, bicuculline can target all GABAA receptors, including those in MSNs. The disinhibition effect through GABAergic neurons may counterbalance the direct inhibitory effect on cholinergic interneurons and thus confuse the result. We partially overcame this challenge by applying L-838,417, which can selectively potentiate α2-GABAA receptors (Petrache et al., 2019; McKernan et al., 2000). Surprisingly, we showed that bath application of L-838,417 decreased the spiking rate of cholinergic interneurons in slice recordings, which suggests that the α2-GABAA receptor may be a regulator of cholinergic interneuron spiking in the NAc. As cholinergic interneurons only contribute about 2% of NAc neurons (Kreitzer, 2009; Castro and Bruchas, 2019), scattered expression of α2-GABAA receptors in MSNs may buffer the difference resulting from cholinergic interneurons by western blot analysis (Mitchell et al., 2018; Koo et al., 2014). Thus, we conducted immunohistochemical experiments to support our western blotting results for GABAA receptor expression in the NAc (Figure 3J,K).

MeCP2 is a transcriptional regulator that binds broadly throughout the genome and regulates the expression of thousands of genes (Chahrour et al., 2008; Cheng and Qiu, 2014; Zhao et al., 2013). Previous microarray analysis of gene expression profiles in Mecp2-null and Mecp2-Tg mice using hypothalamic RNA revealed dysregulation of the Gabra2 gene in those mouse models (Chahrour and Zoghbi, 2007; Hogart et al., 2007; Samaco et al., 2005). As α2-containing GABAA-receptor selective drugs do not induce tolerance (Vinkers et al., 2012), they provide an attractive molecular target for treatment of fear-related neuropsychiatric disorders. However, further studies are required to investigate how MeCP2 regulates the expression of α2-GABAA receptors in the NAc.

Taken together, our results highlight the role of MeCP2 in regulating GABAA α2 receptor function in NAc cholinergic interneurons, suggesting a new cellular and molecular mechanism for Mecp2 in RTT-like phenotypes, and providing strong evidence that modulation of the NAc may ameliorate fear-related disorders.

Materials and methods

Key resources table.

Reagent type
(species) or resource
Designation Source or reference Identifiers Additional
information
Genetic reagent (M. musculus) ChatCre Jackson Laboratory Jax No.006410
Genetic reagent (M. musculus) MeCP2 Flox/- Jackson Laboratory Jax No.006847
Antibody Goat polyclonal anti-ChAT Millipore Cat# AB144P IHC: 1:100
Antibody Rabbit monoclonal anti-MeCP2 Cell Signaling Technology Cat#3456 s IHC: 1:200
Antibody Mouse monoclonal anti-PV Swant Cat#PV235 IHC: 1:1 000
Antibody Rabbit polyclonal GABAA receptor α1 Millipore Cat#06–868 IHC: 1:1 000
WB: 1:500
Antibody Rabbit polyclonal
GABAA receptor α2
Synaptic System Cat#224 103 IHC: 1:1 000
Antibody Rabbit polyclonal
GABAA receptor α2
Abcam Cat#ab72445 WB: 1:500
Antibody Rabbit monoclonal anti-GAPDH Cell Signaling Technology Cat#5014S WB: 1:5000

Mouse strains

To specifically delete Mecp2 in ChAT-positive cholinergic neurons, Chat-Mecp2-/y mice were generated by breeding female Mecp2flox/-mice (Jax No.006847) with ChatCre (Jax No.006410) heterozygous male mice. Mice were group-housed and maintained under standard housing conditions in a temperature (22–25°C)- and humidity (40%)-controlled animal room under a 12 hr light/dark cycle (8:00 am to 8:00 pm) with ad libitum access to food and water. Only animals with cannula implants were housed separately. All mice belonged to the C57BL/6J strain and were housed 3–5 per cage.

Behavioral assays

Male mice at 9 to 13 weeks of age were used for all tests, considering that female mice are typically mosaic at the cellular level for MeCP2 expression, which may contribute to phenotype variability. We first evaluated the mice for general health, including body weight and fur appearance. The mice were then transferred to the animal facility one week before the behavioral tests. They were allowed to habituate to the testing room for 30 min before test commencement. All the behavior chambers were cleaned with 75% ethanol, except the chambers in fear retrieval tests. All behavioral tests were carried out blind to genotype with age-matched male littermates.

Open field test

Spontaneous locomotor activity was assessed for 15 min in an arena (45 × 45 × 45 cm). Experiments were conducted under low-light conditions to minimize anxiety effects. Locomotor activity was evaluated as the total distance traveled. Immobility time was evaluated as the time that mice showed the absence of movement over 2000 ms by ANYmaze software.

Fear conditioning test

The fear conditioning test was performed as described previously, with some modifications (Li et al., 2011). A 30-second-train tone (4000 Hz, 80 db) was used as CS and the electric footshock (0.5 mA, 1.5 ms) was used as US. The conditioning session including four trials. The test for context retrieval was performed in the same chamber for 5 min 22 hr after the training. The tone test was conducted 4 hr later. Mice were placed in another chamber with different context for 3 min as baseline, followed by 3 min with tone stimuli presented. While the conditioning context was cleaned with 75% ethanol, the retrieval context and the chamber used in tone fear test were wiped down with 0.3% acetic acid. All events in the fear conditioning test were programmed, and data were recorded through the MED software (MED Associate Inc). Recorded videos were analyzed by Video Freeze Software (MEF Associate Inc). Freezing was defined as motion index <18 for 1 s as the MED software recommended.

Pain threshold test

A mouse was placed into the conditioning chamber. Every 30 s, a 2 s footshock with 0.05-mA increments (starting from 0 mA) was presented after habituation for 1 min. Two experimenters without prior knowledge of genotypes or shock intensities scored the vocalization responses. Mouse behavior in the chamber was videotaped for analysis of first signs for discomfort and jumping.

Immunohistochemistry

Immunohistochemical experiments were performed following standard procedures (Zhang et al., 2016b). Images were taken using confocal microscopy (Nikon A1 and Olympus FV3000 Confocal Microscope). For the primary antibodies, we used antibodies for ChAT (Millipore, cat. no. AB144P, 1:100), MeCP2 (Cell Signaling Technology, cat. no. 3456 s, 1:200), PV (Swant, cat. no. PV235, 1:1 000), GABAA receptor α1 (Millipore, cat. no. 06–868, 1:1 000), and GABAA receptor α2 (Synaptic System, cat. no. 224 103, 1:1 000).

Western blot analysis

We performed western blot experiments as described previously (Rodriguez-Romaguera et al., 2012). Brains were quickly dissected and the NAc was homogenized in lysis buffer (Beyotime Biotechnology, China) containing 1 mM protease inhibitor PMSF (Beyotime Biotechnology, China). Protein samples were loaded on 10% acrylamide SDS-PAGE gels and then transferred to nitrocellulose membranes. The membranes were incubated with appropriate primary and secondary antibodies, and then visualized by X-ray film exposure (ECL kit, Thermo Scientific). For primary antibodies, we used antibodies for GABAA receptor α1 (Millipore, cat. no. 06–868, 1:200), GABAA receptor α2 (Abcam, cat. no. ab72445, 1:500), and GAPDH (Cell Signaling Technology, cat. no. 5014S, 1:5000).

Preparation of acute slices and electrophysiology

We anesthetized and decapitated 8–12 week-old mice and prepared 350 μm coronal slices using a Vibroslice (Leica VT 1000S, USA) in ice-cold artificial cerebrospinal fluid (ACSF) (composition in mM: 125 NaCl, 3 KCl, 1.25 NaH2PO4, 2 MgSO4, 2 CaCl2, 25 NaHCO3, 10 glucose). The slices were recovered in ACSF at 33°C for 30 min and then kept at room temperature until recording. All solutions were saturated with 95% O2 and 5% CO2. Acute slices were transferred to a recording chamber and fully submerged in continuously perfused (~2 ml/min) ACSF at 25°C. Fluorescent neurons were visually identified under an upright microscope (Nikon, Eclipse FN1) equipped with an infrared-sensitive CCD camera and ×40 water-immersion lens (Nikon, Eclipse FN1). To measure the spontaneous spiking rate of cholinergic interneurons, neurons were patched in a cell-attached configuration and then in whole-cell configuration with electrodes containing the following (in mM): 130 potassium gluconate, 20 KCl, 10 HEPES buffer, 4 Mg-ATP, 0.3 Na-GTP, 10 disodium phosphocreatine and 0.2 EGTA, pH 7.25 with KOH, 288 mOsm. In the whole-cell mode, spontaneous firing was recorded at resting membrane potential. If neurons were not spontaneously active, we discarded the recording. Membrane time constant (Tau) was measured with a single exponential fit of the voltage deflection produced by a small hyperpolarizing current injection from the holding potential (−70 mV). The shape parameters were measured from action potentials by 500 ms current injection and analyzed with MATLAB (MathWorks). Most analyses were performed in Clampfit v10.5 (Axon Instruments, USA). For sIPSC recordings, neurons were clamped in the presence of DNQX (20 μM), and AP5 (50 μM). Microelectrodes were filled with a solution containing 120 mM CsCl, 20 mM Cs-methanesulfonate, 5 mM NaCl, 1 mM MgCl2.6H2O, 10 mM HEPES, 0.2 mM EGTA, 2 mM MgATP, 0.5 mM NaGTP, 0.5 mM spermine, and 5 mM QX314 Chloride; the pH was adjusted to 7.25 with 10 M CsOH. For mIPSC recordings, neurons were clamped at −70 mV in the presence of TTX (1 μM), DNQX (20 μM), and AP5 (50 μM). The intracellular solution contained CsCl 130 mM, NaCl 4 mM, TEA 10 mM, HEPES 10 mM, Na2-ATP 2 mM, Na3-GTP 0.5 mM, and EGTA 0.2 mM. For mEPSC recordings, neurons were clamped at −70 mV in the presence of TTX (1 μM) and picrotoxin (100 μM). We used 130 mM CsMeSO3 to replace CsCl. The synaptic current was then analyzed with Mini60 (Synaptosoft Inc). Photostimulation was applied using a 473 nm laser coupled to an optical fiber controlled by a laser driver (DPSSL II) and digital commands from the Digidata 1440A. Light power at the specimen was ~20 mW/mm2. Light was delivered constantly at 8 Hz for Chat-Mecp2-/y mice. Pipette resistance ranged from 3 to 5 MΩ. Recordings were Bessel-filtered at 10 KHz and sampled at 100 KHz. Access resistance was continuously monitored for each cell. Only neurons with series resistance below 20 MΩ and changing <20% throughout the recording were used for analysis.

Stereotaxic surgery

The AAV viruses AAV-DIO-ChR2(H134R)-GFP and AAV-DIO-NpHR-mCherry, were purchased from S&E Shanghai Medical Biotechnology Company (China). AAV-DIO-hM3Dq-mCherry, AAV-DIO-hM4Di-mCherry, AAV-DIO-mCherry, and AAV-DIO-GFP were purchased from Shanghai Taitool Bioscience Company (China). AAV-FLEX-Mecp2-GFP was provided by Z.L. Qiu (Institute of Neuroscience, Chinese Academy of Sciences, China).

For α2-GABAA receptor knockdown, the following short-hairpin sequence was used: 5’-CTGTCTCAGATACAGATATGG-3’. Both the specificity and efficiency of the shRNA were validated and the high titers of engineered AAV-FLEX-α2(RNAi)-GFP and AAV-FLEX-α2(scramble control)-GFP were produced by S&E Shanghai Medical Biotechnology Company (China).

Standard surgical procedures were followed for stereotaxic injection. Briefly, 6–8 week-old male mice were anesthetized with 2% isoflurane and mounted on a custom-built mouse stereotaxic device for surgery. Heart rate and body temperature were continuously monitored. Eye drops were applied to prevent drying. The animals received stereotaxic injections of AAV to the NAc or MS. Coordinates used for MS injection were AP + 0.98 mm and DV −4.5 mm (150 nl) and for NAc injection were AP + 1.1 mm, ML ±1.3 mm, and DV −4.5 mm (200 nl per side). For NAc subregions, we injected 80 nl of virus per side (NAc core: AP + 1.1 mm, ML ±1.3 mm, and DV −4.5 mm; NAc medial shell: AP + 1.1 mm, ML ±0.5 mm, and DV −4.35 mm; NAc ventral medial shell: AP + 1.1 mm, ML ±0.5 mm, and DV −4.75 mm). The AAV vector was delivered with a glass microelectrode into the target coordinates over a 10 min period. Three weeks after the introduction of the viral vector, behavioral tests were performed. A double-cannula with CC 2.6 mm (RWD Life Science, China) was implanted into the bilateral NAc (AP + 1.1 mm, ML ±1.3 mm, and DV −4.4 mm). For each mouse, the cannula was secured using dental cement. After a week of recovery, the mice were subjected to behavioral tests.

In vivo optogenetic and chemogenetic manipulations

For in vivo optogenetic manipulation, an optical fiber cannula (length 5 mm, NA = 0.22; Inper Inc) was bilaterally implanted into the NAc (AP + 1.1 mm, ML ±1.3 mm, and DV −4.3 mm) and secured using dental cement during the same surgery procedure as for the viral injection. During the behavioral tests, the optical fibers were connected to a laser source using an optical fiber sleeve (Inper Inc). We applied a 5 ms, 8 Hz, continuous 470 nm blue laser stimulation for NAc cholinergic interneurons or continuous 590 nm yellow laser stimulation during the training period of fear conditioning. For chemogenetic manipulation, three weeks after the introduction of AAV-DIO-hM3Dq-mCherry or AAV-DIO-hM4Di-mCherry, CNO (Sigma) was injected intraperitoneally 30 min before conditioning at a dose of 1 mg kg−1.

Quantification and statistical analyses

All data were analyzed using commercially available statistical software packages (Prism five and SPSS v17.0). Sample size was estimated using power analysis based on our preliminary experiments. Data distribution in each experiment was checked for normality before further analysis. Statistical differences were calculated using unpaired two-tailed t-tests when comparing two groups or one-way analysis of variance (ANOVA) with Bonferroni’s multiple comparison test when comparing three groups with one factor or two-way ANOVA with Tukey’s multiple comparison test when constructing learning curves. For comparison of pre- and post-medicine or light application, paired-sample t-tests were used. Statistical significance was defined as p<0.05.

Acknowledgements

We are grateful to ZL Qiu (Institute of Neuroscience, Chinese Academy of Sciences) for providing the AAV/Mecp2 plasmid. We thank GP Feng (Massachusetts Institute of Technology, USA) and Kathleen Quast (Massachusetts Institute of Technology, USA) for insightful comments and editing of the manuscript. We are also grateful to the Core Facilities of Zhejiang University Institute of Neuroscience for technical assistance. This work was supported by the National Key Research and Development Plan of Ministry of Science and Technology of China (2016YF051000), Key Project of the National Natural Science Foundation of China (31430034), Science and Technology Program of Guangdong (2018B030334001), Key Realm R and D Program of Guangdong Province (2019B030335001), Funds for Creative Research Groups of China from the National Natural Science Foundation of China (81521062), and Non-Profit Central Research Institute Fund of the Chinese Academy of Medical Sciences (2019PT310023) to XM Li.

Funding Statement

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Contributor Information

Xiao-Ming Li, Email: lixm@zju.edu.cn.

Mary Kay Lobo, University of Maryland, United States.

Kate M Wassum, University of California, Los Angeles, United States.

Funding Information

This paper was supported by the following grants:

  • Chinese Ministry of Science and Technology National Key Research and Development Plan 2016YF051000 to Xiao-Ming Li.

  • National Natural Science Foundation of China 31430034 to Xiao-Ming Li.

  • Guangdong Science and Technology Department 2018B030334001 to Xiao-Ming Li.

  • National Natural Science Foundation of China Funds for Creative Research Groups 81521062 to Xiao-Ming Li.

  • Chinese Academy of Medical Sciences Non-Profit Central Research Institute Fund 2019PT310023 to Xiao-Ming Li.

  • Government of Guangdong Province Key Realm R&D Program of Guangdong Province 2019B030335001 to Xiao-Ming Li.

Additional information

Competing interests

No competing interests declared.

Author contributions

Conceptualization, Resources, Data curation, Software, Supervision, Validation, Investigation, Methodology, Writing - original draft, Project administration, Writing - review and editing.

Data curation, Software, Validation, Investigation, Methodology, Project administration, Writing - review and editing.

Data curation, Validation, Investigation, Methodology, Project administration, Writing - review and editing.

Data curation, Investigation, Methodology, Writing - original draft, Project administration.

Investigation, Methodology.

Data curation, Software, Investigation, Project administration.

Investigation, Project administration.

Data curation, Software, Methodology.

Data curation, Software, Methodology.

Data curation, Software, Methodology.

Data curation, Investigation.

Investigation.

Resources, Investigation, Methodology.

Writing - review and editing.

Conceptualization, Resources, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Project administration, Writing - review and editing.

Ethics

Animal experimentation: Mouse care and use followed the guidelines of the Animal Advisory Committee at Zhejiang University and the US National Institutes of Health Guidelines for the Care and Use of Laboratory Animals. The care and use of the mice in this work were reviewed and approved by the Animal Advisory Committee at Zhejiang University (ZJU201553001). Every effort was made to minimize suffering.

Additional files

Transparent reporting form

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1, 2, 3, 4, 5 and 6.

References

  1. Adachi M, Autry AE, Covington HE, Monteggia LM. MeCP2-mediated transcription repression in the basolateral amygdala may underlie heightened anxiety in a mouse model of rett syndrome. Journal of Neuroscience. 2009;29:4218–4227. doi: 10.1523/JNEUROSCI.4225-08.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adolphs R. The biology of fear. Current Biology. 2013;23:R79–R93. doi: 10.1016/j.cub.2012.11.055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aitta-Aho T, Hay YA, Phillips BU, Saksida LM, Bussey TJ, Paulsen O, Apergis-Schoute J. Basal forebrain and brainstem cholinergic neurons differentially impact amygdala circuits and Learning-Related behavior. Current Biology. 2018;28:2557–2569. doi: 10.1016/j.cub.2018.06.064. [DOI] [PubMed] [Google Scholar]
  4. Ballinger EC, Schaaf CP, Patel AJ, de Maio A, Tao H, Talmage DA, Zoghbi HY, Role LW. Mecp2 deletion from cholinergic neurons selectively impairs recognition memory and disrupts cholinergic modulation of the perirhinal cortex. Eneuro. 2019;6:ENEURO.0134-19.2019. doi: 10.1523/ENEURO.0134-19.2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bennett BD, Wilson CJ. Spontaneous activity of neostriatal cholinergic interneurons in vitro. The Journal of Neuroscience. 1999;19:5586–5596. doi: 10.1523/JNEUROSCI.19-13-05586.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brown MT, Tan KR, O'Connor EC, Nikonenko I, Muller D, Lüscher C. Ventral tegmental area GABA projections pause accumbal cholinergic interneurons to enhance associative learning. Nature. 2012;492:452–456. doi: 10.1038/nature11657. [DOI] [PubMed] [Google Scholar]
  7. Cardinal RN, Parkinson JA, Hall J, Everitt BJ. Emotion and motivation: the role of the Amygdala, ventral striatum, and prefrontal cortex. Neuroscience & Biobehavioral Reviews. 2002;26:321–352. doi: 10.1016/S0149-7634(02)00007-6. [DOI] [PubMed] [Google Scholar]
  8. Castro DC, Bruchas MR. A motivational and neuropeptidergic hub: anatomical and functional diversity within the nucleus accumbens shell. Neuron. 2019;102:529–552. doi: 10.1016/j.neuron.2019.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science. 2008;320:1224–1229. doi: 10.1126/science.1153252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chahrour M, Zoghbi HY. The story of rett syndrome: from clinic to neurobiology. Neuron. 2007;56:422–437. doi: 10.1016/j.neuron.2007.10.001. [DOI] [PubMed] [Google Scholar]
  11. Chao HT, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J, Neul JL, Gong S, Lu HC, Heintz N, Ekker M, Rubenstein JL, Noebels JL, Rosenmund C, Zoghbi HY. Dysfunction in GABA signalling mediates autism-like stereotypies and rett syndrome phenotypes. Nature. 2010;468:263–269. doi: 10.1038/nature09582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chen RZ, Akbarian S, Tudor M, Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nature Genetics. 2001;27:327–331. doi: 10.1038/85906. [DOI] [PubMed] [Google Scholar]
  13. Cheng J, Umschweif G, Leung J, Sagi Y, Greengard P. HCN2 channels in cholinergic interneurons of nucleus accumbens shell regulate depressive behaviors. Neuron. 2019;101:662–672. doi: 10.1016/j.neuron.2018.12.018. [DOI] [PubMed] [Google Scholar]
  14. Cheng TL, Qiu Z. MeCP2: multifaceted roles in gene regulation and neural development. Neuroscience Bulletin. 2014;30:601–609. doi: 10.1007/s12264-014-1452-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Correia SS, McGrath AG, Lee A, Graybiel AM, Goosens KA. Amygdala-ventral striatum circuit activation decreases long-term fear. eLife. 2016;5:e12667. doi: 10.7554/eLife.12669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. de Jong JW, Afjei SA, Pollak Dorocic I, Peck JR, Liu C, Kim CK, Tian L, Deisseroth K, Lammel S. A neural circuit mechanism for encoding aversive stimuli in the mesolimbic dopamine system. Neuron. 2019;101:133–151. doi: 10.1016/j.neuron.2018.11.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Deng JV, Rodriguiz RM, Hutchinson AN, Kim IH, Wetsel WC, West AE. MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants. Nature Neuroscience. 2010;13:1128–1136. doi: 10.1038/nn.2614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Dong P, Wang H, Shen XF, Jiang P, Zhu XT, Li Y, Gao JH, Lin S, Huang Y, He XB, Xu FQ, Duan S, Lian H, Wang H, Chen J, Li XM. A novel cortico-intrathalamic circuit for flight behavior. Nature Neuroscience. 2019;22:941–949. doi: 10.1038/s41593-019-0391-6. [DOI] [PubMed] [Google Scholar]
  19. Farrant M, Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nature Reviews Neuroscience. 2005;6:215–229. doi: 10.1038/nrn1625. [DOI] [PubMed] [Google Scholar]
  20. Floresco SB. The nucleus accumbens: an interface between cognition, emotion, and action. Annual Review of Psychology. 2015;66:25–52. doi: 10.1146/annurev-psych-010213-115159. [DOI] [PubMed] [Google Scholar]
  21. Fritschy JM, Mohler H. GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. The Journal of Comparative Neurology. 1995;359:154–194. doi: 10.1002/cne.903590111. [DOI] [PubMed] [Google Scholar]
  22. Fyffe SL, Neul JL, Samaco RC, Chao HT, Ben-Shachar S, Moretti P, McGill BE, Goulding EH, Sullivan E, Tecott LH, Zoghbi HY. Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress. Neuron. 2008;59:947–958. doi: 10.1016/j.neuron.2008.07.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gemelli T, Berton O, Nelson ED, Perrotti LI, Jaenisch R, Monteggia LM. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of rett syndrome in mice. Biological Psychiatry. 2006;59:468–476. doi: 10.1016/j.biopsych.2005.07.025. [DOI] [PubMed] [Google Scholar]
  24. Groessl F, Munsch T, Meis S, Griessner J, Kaczanowska J, Pliota P, Kargl D, Badurek S, Kraitsy K, Rassoulpour A, Zuber J, Lessmann V, Haubensak W. Dorsal tegmental dopamine neurons gate associative learning of fear. Nature Neuroscience. 2018;21:952–962. doi: 10.1038/s41593-018-0174-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Gross CT, Canteras NS. The many paths to fear. Nature Reviews Neuroscience. 2012;13:651–658. doi: 10.1038/nrn3301. [DOI] [PubMed] [Google Scholar]
  26. Guy J, Hendrich B, Holmes M, Martin JE, Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic rett syndrome. Nature Genetics. 2001;27:322–326. doi: 10.1038/85899. [DOI] [PubMed] [Google Scholar]
  27. Hasselmo ME. The role of acetylcholine in learning and memory. Current Opinion in Neurobiology. 2006;16:710–715. doi: 10.1016/j.conb.2006.09.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Higley MJ, Soler-Llavina GJ, Sabatini BL. Cholinergic modulation of multivesicular release regulates striatal synaptic potency and integration. Nature Neuroscience. 2009;12:1121–1128. doi: 10.1038/nn.2368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Hikida T, Morita M, Macpherson T. Neural mechanisms of the nucleus accumbens circuit in reward and aversive learning. Neuroscience Research. 2016;108:1–5. doi: 10.1016/j.neures.2016.01.004. [DOI] [PubMed] [Google Scholar]
  30. Hogart A, Nagarajan RP, Patzel KA, Yasui DH, Lasalle JM. 15q11-13 GABAA receptor genes are normally Biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders. Human Molecular Genetics. 2007;16:691–703. doi: 10.1093/hmg/ddm014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Hu H. Reward and aversion. Annual Review of Neuroscience. 2016;39:297–324. doi: 10.1146/annurev-neuro-070815-014106. [DOI] [PubMed] [Google Scholar]
  32. Ito-Ishida A, Ure K, Chen H, Swann JW, Zoghbi HY. Loss of MeCP2 in Parvalbumin-and Somatostatin-Expressing neurons in mice leads to distinct rett Syndrome-like phenotypes. Neuron. 2015;88:651–658. doi: 10.1016/j.neuron.2015.10.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Janak PH, Tye KM. From circuits to behaviour in the amygdala. Nature. 2015;517:284–292. doi: 10.1038/nature14188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Jiang L, Kundu S, Lederman JD, López-Hernández GY, Ballinger EC, Wang S, Talmage DA, Role LW. Cholinergic signaling controls conditioned fear behaviors and enhances plasticity of Cortical-Amygdala circuits. Neuron. 2016;90:1057–1070. doi: 10.1016/j.neuron.2016.04.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Johansen JP, Hamanaka H, Monfils MH, Behnia R, Deisseroth K, Blair HT, LeDoux JE. Optical activation of lateral amygdala pyramidal cells instructs associative fear learning. PNAS. 2010;107:12692–12697. doi: 10.1073/pnas.1002418107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Kitabatake Y, Hikida T, Watanabe D, Pastan I, Nakanishi S. Impairment of reward-related learning by cholinergic cell ablation in the striatum. PNAS. 2003;100:7965–7970. doi: 10.1073/pnas.1032899100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Koo JW, Lobo MK, Chaudhury D, Labonté B, Friedman A, Heller E, Peña CJ, Han MH, Nestler EJ. Loss of BDNF signaling in D1R-expressing NAc neurons enhances morphine reward by reducing GABA inhibition. Neuropsychopharmacology. 2014;39:2646–2653. doi: 10.1038/npp.2014.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Kreitzer AC. Physiology and pharmacology of striatal neurons. Annual Review of Neuroscience. 2009;32:127–147. doi: 10.1146/annurev.neuro.051508.135422. [DOI] [PubMed] [Google Scholar]
  39. Lavoie AM, Tingey JJ, Harrison NL, Pritchett DB, Twyman RE. Activation and deactivation rates of recombinant GABA(A) receptor channels are dependent on alpha-subunit isoform. Biophysical Journal. 1997;73:2518–2526. doi: 10.1016/S0006-3495(97)78280-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Lee J, Finkelstein J, Choi JY, Witten IB. Linking cholinergic interneurons, synaptic plasticity, and behavior during the extinction of a Cocaine-Context association. Neuron. 2016;90:1071–1085. doi: 10.1016/j.neuron.2016.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. LeGates TA, Kvarta MD, Tooley JR, Francis TC, Lobo MK, Creed MC, Thompson SM. Reward behaviour is regulated by the strength of hippocampus–nucleus accumbens synapses. Nature. 2018;564:258–262. doi: 10.1038/s41586-018-0740-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Letzkus JJ, Wolff SB, Meyer EM, Tovote P, Courtin J, Herry C, Lüthi A. A disinhibitory microcircuit for associative fear learning in the auditory cortex. Nature. 2011;480:331–335. doi: 10.1038/nature10674. [DOI] [PubMed] [Google Scholar]
  43. Li H, Zhong X, Chau KF, Williams EC, Chang Q. Loss of activity-induced phosphorylation of MeCP2 enhances synaptogenesis, LTP and spatial memory. Nature Neuroscience. 2011;14:1001–1008. doi: 10.1038/nn.2866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Li H, Penzo MA, Taniguchi H, Kopec CD, Huang ZJ, Li B. Experience-dependent modification of a central amygdala fear circuit. Nature Neuroscience. 2013;16:332–339. doi: 10.1038/nn.3322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Likhtik E, Johansen JP. Neuromodulation in circuits of aversive emotional learning. Nature Neuroscience. 2019;22:1586–1597. doi: 10.1038/s41593-019-0503-3. [DOI] [PubMed] [Google Scholar]
  46. Luchicchi A, Bloem B, Viaña JN, Mansvelder HD, Role LW. Illuminating the role of cholinergic signaling in circuits of attention and emotionally salient behaviors. Frontiers in Synaptic Neuroscience. 2014;6:24. doi: 10.3389/fnsyn.2014.00024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Lyst MJ, Bird A. Rett syndrome: a complex disorder with simple roots. Nature Reviews Genetics. 2015;16:261–275. doi: 10.1038/nrg3897. [DOI] [PubMed] [Google Scholar]
  48. Mamaligas AA, Ford CP. Spontaneous synaptic activation of muscarinic receptors by striatal cholinergic neuron firing. Neuron. 2016;91:574–586. doi: 10.1016/j.neuron.2016.06.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Maren S, Quirk GJ. Neuronal signalling of fear memory. Nature Reviews Neuroscience. 2004;5:844–852. doi: 10.1038/nrn1535. [DOI] [PubMed] [Google Scholar]
  50. McKernan RM, Rosahl TW, Reynolds DS, Sur C, Wafford KA, Atack JR, Farrar S, Myers J, Cook G, Ferris P, Garrett L, Bristow L, Marshall G, Macaulay A, Brown N, Howell O, Moore KW, Carling RW, Street LJ, Castro JL, Ragan CI, Dawson GR, Whiting PJ. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nature Neuroscience. 2000;3:587–592. doi: 10.1038/75761. [DOI] [PubMed] [Google Scholar]
  51. Mitchell SJ, Maguire EP, Cunningham L, Gunn BG, Linke M, Zechner U, Dixon CI, King SL, Stephens DN, Swinny JD, Belelli D, Lambert JJ. Early-life adversity selectively impairs α2-GABAA receptor expression in the mouse nucleus accumbens and influences the behavioral effects of cocaine. Neuropharmacology. 2018;141:98–112. doi: 10.1016/j.neuropharm.2018.08.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Moretti P, Levenson JM, Battaglia F, Atkinson R, Teague R, Antalffy B, Armstrong D, Arancio O, Sweatt JD, Zoghbi HY. Learning and memory and synaptic plasticity are impaired in a mouse model of rett syndrome. Journal of Neuroscience. 2006;26:319–327. doi: 10.1523/JNEUROSCI.2623-05.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Paton JJ, Belova MA, Morrison SE, Salzman CD. The primate amygdala represents the positive and negative value of visual stimuli during learning. Nature. 2006;439:865–870. doi: 10.1038/nature04490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Petrache AL, Rajulawalla A, Shi A, Wetzel A, Saito T, Saido TC, Harvey K, Ali AB. Aberrant Excitatory-Inhibitory synaptic mechanisms in entorhinal cortex microcircuits during the pathogenesis of Alzheimer's Disease. Cerebral Cortex. 2019;29:1834–1850. doi: 10.1093/cercor/bhz016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Picciotto MR, Higley MJ, Mineur YS. Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior. Neuron. 2012;76:116–129. doi: 10.1016/j.neuron.2012.08.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Qiu Z. Deciphering MECP2-associated disorders: disrupted circuits and the hope for repair. Current Opinion in Neurobiology. 2018;48:30–36. doi: 10.1016/j.conb.2017.09.004. [DOI] [PubMed] [Google Scholar]
  57. Reijmers LG, Perkins BL, Matsuo N, Mayford M. Localization of a stable neural correlate of associative memory. Science. 2007;317:1230–1233. doi: 10.1126/science.1143839. [DOI] [PubMed] [Google Scholar]
  58. Reiss AL, Faruque F, Naidu S, Abrams M, Beaty T, Bryan RN, Moser H. Neuroanatomy of rett syndrome: a volumetric imaging study. Annals of Neurology. 1993;34:227–234. doi: 10.1002/ana.410340220. [DOI] [PubMed] [Google Scholar]
  59. Ren J, Qin C, Hu F, Tan J, Qiu L, Zhao S, Feng G, Luo M. Habenula "cholinergic" neurons co-release glutamate and acetylcholine and activate postsynaptic neurons via distinct transmission modes. Neuron. 2011;69:445–452. doi: 10.1016/j.neuron.2010.12.038. [DOI] [PubMed] [Google Scholar]
  60. Reynolds SM, Berridge KC. Emotional environments retune the valence of appetitive versus fearful functions in nucleus accumbens. Nature Neuroscience. 2008;11:423–425. doi: 10.1038/nn2061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Rodriguez-Romaguera J, Do Monte FH, Quirk GJ. Deep brain stimulation of the ventral striatum enhances extinction of conditioned fear. PNAS. 2012;109:8764–8769. doi: 10.1073/pnas.1200782109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Rudolph U, Knoflach F. Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes. Nature Reviews Drug Discovery. 2011;10:685–697. doi: 10.1038/nrd3502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Rudolph U, Möhler H. Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annual Review of Pharmacology and Toxicology. 2004;44:475–498. doi: 10.1146/annurev.pharmtox.44.101802.121429. [DOI] [PubMed] [Google Scholar]
  64. Russo SJ, Nestler EJ. The brain reward circuitry in mood disorders. Nature Reviews Neuroscience. 2013;14:609–625. doi: 10.1038/nrn3381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Samaco RC, Hogart A, LaSalle JM. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: mecp2 deficiency causes reduced expression of UBE3A and GABRB3. Human Molecular Genetics. 2005;14:483–492. doi: 10.1093/hmg/ddi045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Shahbazian M, Young J, Yuva-Paylor L, Spencer C, Antalffy B, Noebels J, Armstrong D, Paylor R, Zoghbi H. Mice with truncated MeCP2 recapitulate many rett syndrome features and display hyperacetylation of histone H3. Neuron. 2002;35:243–254. doi: 10.1016/S0896-6273(02)00768-7. [DOI] [PubMed] [Google Scholar]
  67. Shen W, Hamilton SE, Nathanson NM, Surmeier DJ. Cholinergic suppression of KCNQ channel currents enhances excitability of striatal medium spiny neurons. Journal of Neuroscience. 2005;25:7449–7458. doi: 10.1523/JNEUROSCI.1381-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Subramaniam B, Naidu S, Reiss AL. Neuroanatomy in rett syndrome: cerebral cortex and posterior Fossa. Neurology. 1997;48:399–407. doi: 10.1212/WNL.48.2.399. [DOI] [PubMed] [Google Scholar]
  69. Tovote P, Fadok JP, Lüthi A. Neuronal circuits for fear and anxiety. Nature Reviews Neuroscience. 2015;16:317–331. doi: 10.1038/nrn3945. [DOI] [PubMed] [Google Scholar]
  70. Vinkers CH, van Oorschot R, Nielsen EØ, Cook JM, Hansen HH, Groenink L, Olivier B, Mirza NR. GABA(A) receptor α subunits differentially contribute to diazepam tolerance after chronic treatment. PLOS ONE. 2012;7:e43054. doi: 10.1371/journal.pone.0043054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Witten IB, Lin SC, Brodsky M, Prakash R, Diester I, Anikeeva P, Gradinaru V, Ramakrishnan C, Deisseroth K. Cholinergic interneurons control local circuit activity and cocaine conditioning. Science. 2010;330:1677–1681. doi: 10.1126/science.1193771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Xu M, Kobets A, Du J-C, Lennington J, Li L, Banasr M, Duman RS, Vaccarino FM, DiLeone RJ, Pittenger C. Targeted ablation of cholinergic interneurons in the dorsolateral striatum produces behavioral manifestations of tourette syndrome. PNAS. 2015;112:893–898. doi: 10.1073/pnas.1419533112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Yu K, Ahrens S, Zhang X, Schiff H, Ramakrishnan C, Fenno L, Deisseroth K, Zhao F, Luo MH, Gong L, He M, Zhou P, Paninski L, Li B. The central amygdala controls learning in the lateral amygdala. Nature Neuroscience. 2017;20:1680–1685. doi: 10.1038/s41593-017-0009-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Yu AJ, Dayan P. Uncertainty, neuromodulation, and attention. Neuron. 2005;46:681–692. doi: 10.1016/j.neuron.2005.04.026. [DOI] [PubMed] [Google Scholar]
  75. Zahar Y, Morris G. Enhance your chance with the TANs: tonically active neurons support learning in the ventral striatum. Neuron. 2014;82:941–943. doi: 10.1016/j.neuron.2014.05.029. [DOI] [PubMed] [Google Scholar]
  76. Zhang J, Tan L, Ren Y, Liang J, Lin R, Feng Q, Zhou J, Hu F, Ren J, Wei C, Yu T, Zhuang Y, Bettler B, Wang F, Luo M. Presynaptic excitation via GABAB receptors in Habenula cholinergic neurons regulates fear memory expression. Cell. 2016a;166:716–728. doi: 10.1016/j.cell.2016.06.026. [DOI] [PubMed] [Google Scholar]
  77. Zhang Y, Cao SX, Sun P, He HY, Yang CH, Chen XJ, Shen CJ, Wang XD, Chen Z, Berg DK, Duan S, Li XM. Loss of MeCP2 in cholinergic neurons causes part of RTT-like phenotypes via α7 receptor in Hippocampus. Cell Research. 2016b;26:728–742. doi: 10.1038/cr.2016.48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Zhang GW, Shen L, Zhong W, Xiong Y, Zhang LI, Tao HW. Transforming sensory cues into aversive emotion via Septal-Habenular pathway. Neuron. 2018;99:1016–1028. doi: 10.1016/j.neuron.2018.07.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Zhao YT, Goffin D, Johnson BS, Zhou Z. Loss of MeCP2 function is associated with distinct gene expression changes in the striatum. Neurobiology of Disease. 2013;59:257–266. doi: 10.1016/j.nbd.2013.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision letter

Editor: Mary Kay Lobo1

In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

Acceptance summary:

This study investigates a role for a DNA methyl binding protein in fear learning behavior. The study uses a set of elegant experiments to reduce this protein, alter activity, and alter inhibitory receptor function in acetylcholine expressing neurons in a brain region involved with emotional behavior to provide mechanistic insight into fear learning processes. This study has implications for potential mechanisms and brain cell subtypes relevant to fear-related disorders.

Decision letter after peer review:

Thank you for submitting your article "MeCP2 in cholinergic interneurons of nucleus accumbens regulates fear memory" for consideration by eLife. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Kate Wassum as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This study investigates a role for Mecp2 gene deficiency in cholinergic interneurons (CINs) of the nucleus accumbens (NAc) in fear learning. Using ChAT-Mecp2 deficient mice the authors demonstrate deficits in fear memory retrieval, which was partially restored by expressing Mecp2 to NAc CINs. These effects could be mediated through reduced spontaneous activity in NAc CINs, which occurs through enhanced alpha2-GABAA expression. The authors then use a set of elegant experiments to alter activity and/or knock down alpha2-GABAA in NAc CINs in ChAT-Mecp2 or wildtype mice to further provide a mechanistic role into the fear response deficits occurring with Mecp2 deletion in ChAT neurons. Overall these studies provide a new role for Mecp2 in NAc CINs in fear learning and memory processes.

Essential revisions:

1) A major concern with this study is that the optogenetic, chemogenetic, RNAi, and L-838,417 manipulations are performed during fear learning. To support the conclusion that fear memory is disrupted then these manipulations should be applied during the memory retrieval. Such studies would likely take longer than two months. It is recommended by the reviewers that the authors alter their conclusions to support deficits in fear learning rather than fear memory based on the experiments performed.

2) In line with the above comment, in the data in Figure 1F it appears that the Chat-Mecp2 learning is impaired toward the end of training. Is there a significant difference if Chat-Mecp2 mice are compared to the average of the other 3 groups on day/session/presentation 4? Does the “fear memory” difference between groups occur if freezing is calculated against baseline (e.g. as a percentage of baseline responding or similar)? It's commendable that the authors have performed locomotor and spatial memory controls, but if the effects on test are a result of a more pervasive effect on fear regulation, it would simply change the interpretation to suggest that loss of Mecp2 in CINs results in fear learning deficits.

3) Please provide the data for fear learning in Figure 2C-F and Figure 4.

4) The fact that fear memory was affected by NAc CIN manipulations regardless of whether context or fear was tested is important (e.g. Figures 2C-D) and wasn't given enough attention. This is different from what is observed in other regions that are upstream from NAc, such as basolateral amygdala effects which tend to be stimulus-specific, and hippocampal effects which tend to be context-specific. The data in Figure 6C suggests that different NAc subregions might regulate the stimulus/context fear slightly differently, but without any discussion of these findings in the main body of the paper, it's difficult interpret these findings. Could the authors please comment on this? Is it possible that MeCP2 in NAc CINs regulates all types of fear or overall emotion? The pain threshold control tests argue against the latter, thus please address this.

5) The electrophysiology studies lack sufficient animal numbers. For example, 9 neurons from 2 mice; 7 neurons from 2 mice; n = 14 neurons for ACSF, n = 13 neurons for L-838417 (Figure 3 legend), etc. Please increase the animal numbers in each group.

6) In Figure 3 L-M, please compare the inhibitory effect of L-838,417 on the firing and GABAergic currents of both wild type mice and Chat-Mecp2-/y mice.

7) Please rationalize why the experiments were performed in the BF as well as NAc but not medial habenula (MHb) or other cholinergic rich regions. Please also discuss studies about MHb cholinergic neurons in meditating fear responses and how this contrasts to the current studies. Previous work shows that cholinergic projection neurons of the MHb regulate fear memory expression. Activating MHb cholinergic neurons decreases fear response, which indicates that cholinergic neurons in MHb play an inhibitory role (Zhang et al., 2016). This contrasts to the current study showing the cholinergic interneurons in NAc have an excitatory role since chemogenetic and optogenetic stimulation reverses the reduced firing rate and impaired fear memory by deletion of MeCP2 (Figure 4).

8) It is difficult to distinguish immobility and freezing behaviors using automated software. But, freezing is an active fear reaction, while immobility is an absence of movement. Have the authors measured the freezing behaviors as active fear reactions in the open field test? If so, please describe the experimental procedures with details. If not, please describe procedures with appropriate words such as immobility, motor defects, etc.

9) Please rationalize why the α subunits of GABAA receptor were examined. Are GABAA α1 or α2 Receptor subunits target genes of MECP2 or are they enriched in the CINs?

10) The authors discuss a study showing that knock-down of MECP2 in cholinergic interneurons did not show impairment of fear memory and claimed that the inconsistency results from difference in experimental protocols and in cell-types. Was there an age-difference between the two studies? If so please include this in the text.

11) Please provide the numbers of neurons and/or animals used in Figures 3—figure supplement 1, 2, Figure 4—figure supplement 1, and Figure 6—figure supplement 1? In addition, the number of animals in Figure S6 is low and additional animals would support the conclusions. Further, subsection “Inhibition of NAc Cholinergic Interneurons Resulted in Fear Memory Impairment” proposes to examine CINs in different NAC regions (i.e. core, medial shell and ventromedial shell) to ascertain if they differentially regulate fear memory. However, since the data is in supplemental material there is no information about this outcome this in the text. It is suggested that the data in supplemental figure 6 be added to Figure 5 and that a discussion of these results be included in the main body of the paper. Even if the data are mostly null effects this is would be interesting to know.

12) In Figures 6h-6k, the authors calculated p-values with one-way ANOVA with Dunnett's multiple comparisons and additionally performed two-tailed unpaired t-test. Please explain the reason. It would be better to perform a one-way ANOVA with post-hoc analysis.

eLife. 2020 May 18;9:e55342. doi: 10.7554/eLife.55342.sa2

Author response


Essential revisions:

1) A major concern with this study is that the optogenetic, chemogenetic, RNAi, and L-838,417 manipulations are performed during fear learning. To support the conclusion that fear memory is disrupted then these manipulations should be applied during the memory retrieval. Such studies would likely take longer than two months. It is recommended by the reviewers that the authors alter their conclusions to support deficits in fear learning rather than fear memory based on the experiments performed.

This is a really important issue. Considering that all manipulations were applied during fear learning, rather than retrieval, we agree the conclusion of fear memory deficits cannot be drawn based on the existing data. Accordingly, we have revised our conclusion to fear learning deficits throughout manuscript. We sincerely thank the reviewer for this constructive suggestion.

2) In line with the above comment, in the data in Figure 1F it appears that the Chat-Mecp2 learning is impaired toward the end of training. Is there a significant difference if Chat-Mecp2 mice are compared to the average of the other 3 groups on day/session/presentation 4? Does the “fear memory” difference between groups occur if freezing is calculated against baseline (e.g. as a percentage of baseline responding or similar)? It's commendable that the authors have performed locomotor and spatial memory controls, but if the effects on test are a result of a more pervasive effect on fear regulation, it would simply change the interpretation to suggest that loss of Mecp2 in CINs results in fear learning deficits.

The reviewers are correct. Compared to the other 3 control groups, freezing time of Chat-Mecp2 group is significantly decreased on trial 4 (Figure 1—figure supplement 1A). Besides, if freezing is calculated against trial 4 during learning, the “fear memory deficits” with Chat-Mecp2 group disappeared (Figure 1—figure supplement 1B, C), suggesting that the impairment on retrieval day could attribute to fear learning deficits. We thank the reviewers for pointing out this issue. The new data and figures have been added and the interpretation has been revised.

3) Please provide the data for fear learning in Figure 2C-F and Figure 4.

These data have now been included in the manuscript (Figure 2—figure supplement 1 and Figure 4—figure supplement 1D, F).

Figure 2—figure supplement 1

“To test the behavioral effects of MeCP2 restoration in cholinergic neurons, we performed fear conditioning tests. It appeared that fear learning deficit of Chat-Mecp2-/y mice was rescued towards the end of training with MeCP2 restoration in the cholinergic neurons of NAc, but not medial septum (MS) (Figure 2—figure supplement 1).”

Figure 4—figure supplement 1

“Activation of NAc cholinergic interneurons significantly increased the freezing level of Chat-Mecp2-/y mice in the training process (Figure 4—figure supplement 1C), as well as the context and tone fear memory retrieval process (Figure 4B, C).”

“We found that optogenetic activation of cholinergic interneurons (8 Hz) only during fear learning also rescued fear deficits in Chat-Mecp2-/y mice (Figure 4E, F and Figure 4—figure supplement 1E).”

4) The fact that fear memory was affected by NAc CIN manipulations regardless of whether context or fear was tested is important (e.g. Figures 2C-D) and wasn't given enough attention. This is different from what is observed in other regions that are upstream from NAc, such as basolateral amygdala effects which tend to be stimulus-specific, and hippocampal effects which tend to be context-specific. The data in Figure 6C suggests that different NAc subregions might regulate the stimulus/context fear slightly differently, but without any discussion of these findings in the main body of the paper, it's difficult interpret these findings. Could the authors please comment on this? Is it possible that MeCP2 in NAc CINs regulates all types of fear or overall emotion? The pain threshold control tests argue against the latter, thus please address this.

We thank the reviewers for raising these important discussions which have been missing in our original manuscript. As mentioned by the reviewers, other brain regions that are affected in fear regulation always tend to be either context-specific or stimulus-specific. For example, hippocampal lesion produces a severe deficit in the acquired context fear, but not tone fear (Kim et al., 1992, Science). Lesions of the amygdala interfered with the conditioning of fear responses of both the context and tone, whereas its subregion, BLA and LA differentially contribute to context and tone-US association (Calandreau et al., 2005, Learning and Memory). Based on our data, NAc manipulation resulted in alteration of both.

The most probable explanation could be that NAc CIN receives converging input from both HPC and BLA, thus participating in both context and tone fear regulation (Figure 6—figure supplement 2). In particular, the function of BLANAc circuit has been well reported in tone fear behavior (Correia et al., 2016) and HPCNAc circuit in contextual reward behavior (LeGates et al., 2018), indicating the involvement of NAc in both contextual and tone related behaviors.

The NAc is known to be functionally heterogenous with respect to the regulation of positive and negative affect (Hamel et al., 2017; Ito and Hayen et al., 2011). Besides, a recent study also suggested the functional difference of CIN in NAc core and shell, with respect to depressive behaviors (Cheng et al., 2019). Thus, we got curious about the role of CIN within different NAc subregions in fear regulation. According to our result (Figure 5), inhibition of CIN in core and shell have similar effect on tone/context fear, with a slight difference in NAc medial shell. Inhibition of CINs in NAc medial shell impaired tone fear, with context fear intact. This result suggested a potential heterogeneity within NAc shell. Since the anatomical and characteristics of CINs within shell and core are unknown, future studies are necessary in order to compare CINs in different NAc subregions.

NAc is a crucial brain region for emotional valence (Hu, 2016). Our present data suggested that MeCP2 in NAc CINs regulate tone and contextual fear conditioning, both of which are conditioned fear. Importantly, conditioned and innate fear responses seem to be mediated, at least partially, through nonoverlapping circuits (Gross and Canteras, 2012), making it impossible to simply transfer our understanding of NAc CINs in conditioned fear to others. However, we believe it would be interesting to investigate their role in innate fear.

As indicated by the reviewers, our pain threshold test suggested normal pain perception ability with conditional knockout mice, which excluded the possibility that MeCP2 in NAc CINs regulate overall emotion.

We discussed this issue in the revised manuscript in the Discussion session.

5) The electrophysiology studies lack sufficient animal numbers. For example, 9 neurons from 2 mice; 7 neurons from 2 mice; n = 14 neurons for ACSF, n = 13 neurons for L-838417 (Figure 3 legend), etc. Please increase the animal numbers in each group.

We apologize for not stating clearly and lack of sufficient animal numbers for some groups. All electrophysiology groups included neurons from at least 3 animals in the revised manuscript.

6) In Figure 3 L-M, please compare the inhibitory effect of L-838,417 on the firing and GABAergic currents of both wild type mice and Chat-Mecp2-/y mice.

We thank the reviewers for pointing out this important issue. We found potentiation of α2-GABAA receptors with L-838,417 significantly decreased the firing frequency of NAc CHIs in Chat-Mecp2-/y mice (Figure 3—figure supplement 2D). Furthermore, it increased both the frequency and amplitude of sIPSC in NAc slices from both control and Chat-Mecp2-/y mice (Figure 3—figure supplement 2E, F). To be noted, L-838-417 has been reported to increase both the frequency and amplitude of sIPSC with Alzheimer’s disease mouse model (Petrache et al., 2019). As suggested, we have added this part into current manuscript.

Figure 3—figure supplement 2

“Potentiating the α2-GABAA receptors with L-838,417 (2 μM) in bath solution significantly decreased the firing frequency of cholinergic interneurons in NAc slices from both control (Figure 3L, M) and Chat-Mecp2-/y mice (Figure 3—figure supplement 2D). Further, we also compared the effect of L-838,417 on GABAergic current and found that both the frequency and amplitude of sIPSC have been increased after treatment (Figure 3—figure supplement 2E, F).”

7) Please rationalize why the experiments were performed in the BF as well as NAc but not medial habenula (MHb) or other cholinergic rich regions. Please also discuss studies about MHb cholinergic neurons in meditating fear responses and how this contrasts to the current studies. Previous work shows that cholinergic projection neurons of the MHb regulate fear memory expression. Activating MHb cholinergic neurons decreases fear response, which indicates that cholinergic neurons in MHb play an inhibitory role (Zhang et al., 2016). This contrasts to the current study showing the cholinergic interneurons in NAc have an excitatory role since chemogenetic and optogenetic stimulation reverses the reduced firing rate and impaired fear memory by deletion of MeCP2 (Figure 4).

We thank the reviewers for these important questions.

Our previous work (Zhang et al., 2016) suggested that conditional deletion of MECP2 in cholinergic neurons caused several specific RTT phenotypes. Re-expressing MECP2 in basal forebrain cholinergic neurons could rescue most except fear encoding. We thus initiated this study to expand on the knowledge (Year 2014): what cholinergic brain region is responsible for fear encoding deficit with Chat-Mecp2-/y mice? Both NAc and MHb have been reported to be important in mood regulation. However, among all cholinergic nuclei, NAc is the only one that connect directly with both hippocampus and amygdala, two well recognized structures that regulate fear encoding. This suggested the potential role of NAc CINs in fear encoding.

Zhang et al. (Zhang., 2016) revealed that activating cholinergic neurons decreases fear response. This at first seems contradictory to our findings on the role of NAc CINs in promoting fear. However, there are differences in manipulation (ablation and activation with naïve mice vs. activation with knockout mice), which might contribute to different conclusion. Besides, habenular cholinergic neurons contribute to fear memory expression rather than fear encoding. Thanks to reminding from the reviewers, our study revealed the role of NAc CINs in fear encoding. Importantly, since these cholinergic neurons are in different brain regions, it is possible that different circuits they are involved and different molecular they express contributed to distinct roles in fear behavior.

We discussed this issue in the revised manuscript in the Discussion session.

8) It is difficult to distinguish immobility and freezing behaviors using automated software. But, freezing is an active fear reaction, while immobility is an absence of movement. Have the authors measured the freezing behaviors as active fear reactions in the open field test? If so, please describe the experimental procedures with details. If not, please describe procedures with appropriate words such as immobility, motor defects, etc.

We did not measure the freezing behaviors in open field test. Thus, we agree it is inaccurate to use the word “freezing” without appropriate description. To make it clearer, we added the procedure in the Materials and methods part: “Recorded videos were analyzed by Video Freeze Software (MEF Associate Inc). Freezing was defined as motion index < 18 for 1s as the MED software recommended.”

9) Please rationalize why the α subunits of GABAA receptor were examined. Are GABAA α1 or α2 Receptor subunits target genes of MECP2 or are they enriched in the CINs?

We thank the reviewers for pointing this out. Exactly like the reviewers’ predictions, GABAA receptor is a ligand-gated chloride channel composed of two α, two β, and one γ subunits. According to the in-situ data from Allen Brain, β3 subunit is widely expressed in NAc, while α2 is sparsely expressed with a pattern similar to cholinergic neurons. Based on this, we then investigated the specific expression of α2 at CINs with α1 as control.

10) The authors discuss a study showing that knock-down of MECP2 in cholinergic interneurons did not show impairment of fear memory and claimed that the inconsistency results from difference in experimental protocols and in cell-types. Was there an age-difference between the two studies? If so please include this in the text.

We thank the reviewers for pointing out this possibility. There is age difference between these two studies. Ballinger et al. conducted fear conditioning test when mice were 21 weeks old. However, the age of mice we used throughout experiments were between 9 to 12 weeks. Since Rett Syndrome is a neurodevelopmental disorder, there is high possibility that age difference of mice between two studies lead to distinct results. This part has been added into the manuscript in paragraph two of the Discussion.

11) Please provide the numbers of neurons and/or animals used in Figures 3—figure supplement 1, 2, Figure 4—figure supplement 1, and Figure 6—figure supplement 1? In addition, the number of animals in Figure S6 is low and additional animals would support the conclusions. Further, subsection “Inhibition of NAc Cholinergic Interneurons Resulted in Fear Memory Impairment” proposes to examine CINs in different NAC regions (i.e. core, medial shell and ventromedial shell) to ascertain if they differentially regulate fear memory. However, since the data is in supplemental material there is no information about this outcome this in the text. It is suggested that the data in supplemental figure 6 be added to Figure 5 and that a discussion of these results be included in the main body of the paper. Even if the data are mostly null effects this is would be interesting to know.

We apologize for lack of information on neuron/animal numbers and sufficient animals in Figure S6. We agree that it is hard to appreciate the figure since there was no description about its result in the manuscript. Thus, we have moved Figure S6 into Figure 5 as suggested and corresponding discussion has been included in the revised paper. We sincerely thank the reviewers for this constructive suggestion.

12) In Figures 6h-6k, the authors calculated p-values with one-way ANOVA with Dunnett's multiple comparisons and additionally performed two-tailed unpaired t-test. Please explain the reason. It would be better to perform a one-way ANOVA with post-hoc analysis.

We apologize for not stating it clearly. We compared the effect of α2RNAi in three groups (ChatCre mice with control virus, Chat-Mecp2-/y mice with control virus, Chat-Mecp2-/y mice with α2RNAi virus) with one-way ANOVA. We applied t-test to address the effect of inhibition in two groups (Chat-Mecp2-/y mice with α2RNAi virus, Chat-Mecp2-/y mice with α2RNAi virus and NpHR virus). We assumed there are two different factors, so compared them separately with different method. Thank you for pointing this out, we have used one-way ANOVA for this figure in our revised manuscript.

References

Calandreau, L., Desmedt, A., Decorte, L. & Jaffard, R. 2005, A different recruitment of the laterl and basolateral amygdala promotes contexual or elemental conditioned association in pavlovian fear conditioning. Learning & Memory, 12 (4): 383-8.

Hamel, L., Thangarasa, T., Samadi, O. & Ito, R. 2017. Caudal Nucleus Accumbens Core Is Critical in the Regulation of Cue-Elicited Approach-Avoidance Decisions. eneuro, 4.

Ito, R. & Hayen, A. 2011. Opposing roles of nucleus accumbens core and shell dopamine in the modulation of limbic information processing. J Neurosci, 31, 6001-7.

Kim, J. J. & Fanselow, M. S. 1992. Modality-specific retrograde amnesia of fear. Science, 256: 675-677.

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Figure 1—source data 1. Statistical reporting of Figure 1.
    Figure 2—source data 1. Statistical reporting of Figure 2.
    Figure 3—source data 1. Statistical reporting of Figure 3.
    Figure 4—source data 1. Statistical reporting of Figure 4.
    Figure 5—source data 1. Statistical reporting of Figure 5.
    Figure 6—source data 1. Statistical reporting of Figure 6.
    Transparent reporting form

    Data Availability Statement

    All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1, 2, 3, 4, 5 and 6.


    Articles from eLife are provided here courtesy of eLife Sciences Publications, Ltd

    RESOURCES